FRED HUTCHINSON CANCER RESEARCH CENTER: Form 990, tax year 2009

View the entire original 990 at ProPublica ↗

Organization: FRED HUTCHINSON CANCER RESEARCH CENTER (EIN 23-7156071)
Tax period: 2009-07-01 to 2010-06-30
Filed: 2011-05-16
IRS object ID: 201111369349304236
Schema version: 2009v1.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule K
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2011-05-16T11:53:58-07:00	Timestamp
Tax Period End Date	2010-06-30	TaxPeriodEndDate
Return Type	990	ReturnType
Tax Period Begin Date	2009-07-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	237156071	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	FRED HUTCHINSON CANCER RESEARCH CENTER	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Control	FRED	NameControl
Phone	2066674876	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1100 Fairview Avenue North	AddressLine1
City	Seattle	City
State	WA	State
ZIP Code	981091024	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	RANDALL C MAIN	Name
Title	VICE PRESIDENT AND CFO	Title
Phone	2066674876	Phone
Date Signed	2011-05-16	DateSigned

Field	Value	IRS element (for citing)
Tax Year	2009	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	Larry Corey	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	1100 Fairview Avenue North	AddressLine1
City	Seattle	City
State	WA	State
ZIP Code	981091024	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	452845492	GrossReceipts
Group Return For Affiliates	0	GroupReturnForAffiliates
Organization501c	X	Organization501c
Web Site	www.fhcrc.org	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1971	YearFormation
State Legal Domicile	WA	StateLegalDomicile
Activity Or Mission Description	The mission of the Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death. The Center conducts research of the highest standards to improve prevention and treatment of cancer and related diseases.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	20	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	19	NbrIndependentVotingMembers
Total Nbr Employees	3074	TotalNbrEmployees
Total Nbr Volunteers	400	TotalNbrVolunteers
Total Gross UBI	-62064	TotalGrossUBI
Net Unrelated Business Txbl Income	-62064	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	309432567	ContributionsGrantsPriorYear
Contributions Grants Current Year	345330959	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	40814407	ProgramServiceRevenuePriorYear
Program Service Revenue CY	44856905	ProgramServiceRevenueCY
Investment Income Prior Year	5265254	InvestmentIncomePriorYear
Investment Income Current Year	4541566	InvestmentIncomeCurrentYear
Other Revenue Prior Year	9856804	OtherRevenuePriorYear
Other Revenue Current Year	12787637	OtherRevenueCurrentYear
Total Revenue Prior Year	365369032	TotalRevenuePriorYear
Total Revenue Current Year	407517067	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	45565367	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	62506551	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	199547453	SalariesEtcPriorYear
Salaries Etc Current Year	205262594	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	0	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	88717	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	5864611	TotalFundrsngExpCurrentYear
Other Expense Prior Year	127350294	OtherExpensePriorYear
Other Expenses Current Year	120781361	OtherExpensesCurrentYear
Total Expenses Prior Year	372463114	TotalExpensesPriorYear
Total Expenses Current Year	388639223	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	-7094082	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	18877844	RevenuesLessExpensesCY
Total Assets BOY	518509708	TotalAssetsBOY
Total Assets EOY	555798313	TotalAssetsEOY
Total Liabilities BOY	343880000	TotalLiabilitiesBOY
Total Liabilities EOY	362793049	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	174629708	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	193005264	NetAssetsOrFundBalancesEOY
Mission Description	The mission of the Fred Hutchinson Cancer Research Center is the elimination of cancer and related diseases as causes of human suffering and death. The Center conducts research of the highest standards to improve prevention and treatment of cancer and related diseases.	MissionDescription
Significant New Program Services	0	SignificantNewProgramServices
Significant Change	0	SignificantChange
Expense	95909452	Expense
Grants	18286480	Grants
Revenue	3876322	Revenue
Description	Public Health Sciences ("PHS") The goal of the Public Health Sciences Division is to identify strategies that would ultimately reduce the incidence of and mortality from cancer and other diseases. Using large populations as their "laboratory," PHS researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place. This prevention-oriented research also extends to other diseases, including HIV/AIDS, cardiovascular disease, diabetes, and fractures. The PHS Division has statistical, epidemiological and prevention projects that include studies around the world. PHS Division scientists have expertise in coordinating national trials for cancer and acquired immune deficiency syndrome ("AIDS") treatment and prevention, including serving as a coordinating center for one of the nation's largest public health research programs, the Women's Health Initiative. More recently, the PHS Division has gained national stature in genetic epidemiology and in the development of novel methods for the early detection of cancer, including the use of plasma proteomic biomarkers.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	80422079	Expense
Grants	31694954	Grants
Revenue	10778712	Revenue
Description	Clinical Research Division From laboratory bench to bedside, the Clinical Research Division works to develop and analyze new treatments for cancers and other diseases. Researchers seek new or improved ways to cure cancer. Foremost among their contributions has been the development of bone marrow transplantation, a technique that is now saving tens of thousands of lives worldwide annually. In 1990, Dr. E. Donnall Thomas, director emeritus of the Clinical Research Division, received the Nobel Prize in physiology or medicine for his pioneering work developing this technique. Through clinical research, Center scientists continue to refine the techniques of transplantation and extend its use. Once exclusively used for treatment of leukemia, lymphomas and similar diseases, bone marrow transplantation is now being successfully applied to a growing number of diseases, including breast, ovarian and kidney cancer, sickle cell disease and autoimmune disorders such as multiple sclerosis and scleroderma. Other avenues of research being conducted in the Clinical Research Division include immunotherapy, antibody therapy and cancer vaccines. Approximately 450 patients from all over the world receive transplants at the Seattle Cancer Care Alliance coordinated by researchers from the Center's Bone Marrow Transplant Program. The Seattle Cancer Care Alliance, established in 1998, unites the adult and pediatric cancer-care services of the Hutchinson Center, UW Medicine and Seattle Children's. A major focus of SCCA is to speed the transfer of new diagnostic and treatment techniques from the research setting to the patient bedside while providing premier, patient-focused cancer care. Thousands of other cancer patients will be able to receive similar treatment in their local hospitals as a result of the knowledge shared by Clinical Research Division scientists with physicians around the world. Because of the Center's training efforts, many hospitals throughout the United States now perform bone marrow transplants. Scientists in the Center's Clinical Research Division have recorded several "firsts" in cancer research and treatment: Showing that patients with acute leukemia who have failed chemotherapy can be cured with bone marrow transplantation. Showing that bone marrow transplantation is the best form of initial therapy for patients with acute myelogenous leukemia, a disease that affects approximately 15,000 Americans each year. Showing that bone marrow transplantation can cure chronic myelogenous leukemia, a disease that is otherwise incurable and affects approximately 3,000 Americans each year. Developing the first FDA-approved antibody-targeted chemotherapy, making chemotherapy less toxic and more effective. Pioneering the first antibody-targeted therapy against a marker specific to non-Hodgkins lymphoma, an approach now used to treat thousands of people each year. Developing a "tumor paint" that will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells. The tumor paint, derived from scorpion venom, was developed in collaboration with researchers at Seattle Children's Hospital Research Institute. The high quality of the research conducted in the Center's Clinical Research Division is matched only by the quality of care provided to patients receiving treatment.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	101289789	Expense
Grants	8971620	Grants
Revenue	4093776	Revenue
Description	Vaccine and Infectious Disease Division ("VIDD") The Center established VIDD first as an Institute in 2007 and as a scintific division in 2010, toaddress the growing need for treatment and prevention strategies for infectious diseases worldwide. By integrating biometric, laboratory, and clinical science, the researchers at VIDD aim to develop novel vaccines for infectious diseases that threaten global health, to shed light on the workings of the human immune system, and to develop novel treatment and prevention strategies to lessen the burden of infectious diseases and cancers caused by infection, particularly in the immunocompromised host. VIDD research focuses on a wide range of infectious pathogens, including HIV, Herpes Simplex viruses, cytomegalovirus, infectious fungi, and cancer-associated infections such as human herpesvirus-8, among others. Research areas concentrate on treatment and prevention of infectious diseases by studying immune responses to these pathogens, the course of infection, and pursuing various vaccine development strategies. Many of these infections are especially devastating in immunocompromised people, such as HIV positive persons or transplant patients. The HIV Vaccine Trials Network (HVTN), a global network of researchers searching for a safe and effective HIV vaccine, is also headquartered at VIDD. The growing recognition of the importance and challenges of global health research have spurred VIDD scientists to initiate new research directions and collaborations focusing on infectious disease research around the world, including: The Uganda Program on Cancer and Infectious Disease, which is a collaboration between VIDD and the Uganda Cancer Institute to research the 22 percent of cancers worldwide that are caused by infections, to help treat and prevent those cancers, and to train Ugandan doctors in these areas. In part due to high levels of HIV and other infectious viruses that increase risks for various cancers, Uganda, an East African country of more than 27 million people, has among the highest rates of cancer in the world, but only two practicing oncologists; The Discordant Couples project, which encompasses studies of approximately 1,200 couples in Kampala, Uganda and Soweto, South Africa, in which one partner is HIV positive and one is HIV negative. In Africa, the majority of HIV transmissions occur in stable, heterosexual couples via unprotected sex. Thus, studying discordant couples offers the best opportunity to directly measure biological factors influencing the sexual transmission of HIV, as the risk of the uninfected partner contracting HIV is high (between 3 and 10% per year); The China Initiative, which is a collaboration between VIDD, the University of Washington, Seattle Biomedical Research Institute, and several research institutes in China, including the China Center for Disease Control (CCDC) in Beijing and The Institute of Translational Medicine (ITM) at the Sun Yat-sen University in Guangzhou. The goal of the collaboration is to focus on infectious diseases that threaten global health and combine the best resources of each country to enable early identification of infectious disease outbreaks, as well as to accelerate the development of therapeutics to control these diseases. Examples of resources to be shared are scientific datasets, statistical analysis methods, clinical research protocol development and operation, and cross training of our scientific staff. In the future, the dream of VIDD researchers is to find a working HIV vaccine and to make significant contributions in ameliorating the suffering and mortality caused by infectious diseases worldwide. In the short term, VIDD faculty and staff strive to increase knowledge about poorly understood infectious pathogens to inform better treatment, prevention, and vaccine development strategies.	Description

Activity Other ActivityOther

Field	Value	IRS element (for citing)
Expense	86648039	Expense
Grants	3553497	Grants
Revenue	26108095	Revenue
Description	Other program services. (Code: *****) (Expenses $86,648,039 including grants of $39,418,910) (Revenue $26,108,095)	Description

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	86648039	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	3553497	TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev	26108095	TotalOfOtherProgramServiceRev
Total Program Service Expense	364269359	TotalProgramServiceExpense
Described In501 C3	1	DescribedIn501C3
Schedule B Required	1	ScheduleBRequired
Political Activities	0	PoliticalActivities
Lobbying Activities	1	LobbyingActivities
Donor Advised Funds	0	DonorAdvisedFunds
Conservation Easements	0	ConservationEasements
Collections Of Art	1	CollectionsOfArt
Credit Counseling	0	CreditCounseling
Term Or Permanent Endowments	1	TermOrPermanentEndowments
Balance Sheet Amounts Reported	1	BalanceSheetAmountsReported
Independent Audit Financial Stmt	1	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	0	ConsolidatedAuditFinancialStmt
School	0	School
Foreign Office	0	ForeignOffice
Foreign Activities	1	ForeignActivities
More Than5000 K To Organizations	1	MoreThan5000KToOrganizations
More Than5000 K To Individuals	1	MoreThan5000KToIndividuals
Professional Fundraising	1	ProfessionalFundraising
Fundraising Activities	1	FundraisingActivities
Gaming	0	Gaming
Hospital	0	Hospital
Grants To Organizations	1	GrantsToOrganizations
Grants To Individuals	0	GrantsToIndividuals
Schedule J Required	1	ScheduleJRequired
Tax Exempt Bonds	1	TaxExemptBonds
Invest Tax Exempt Bonds	0	InvestTaxExemptBonds
Escrow Account	1	EscrowAccount
On Behalf Of Issuer	0	OnBehalfOfIssuer
Excess Benefit Transaction	0	ExcessBenefitTransaction
Prior Excess Benefit Transaction	0	PriorExcessBenefitTransaction
Loan To Officer Or DQP	0	LoanToOfficerOrDQP
Grant To Related Person	0	GrantToRelatedPerson
Bsnss Rltnshp With Organization	0	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	0	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	1	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	1	DeductibleNonCashContributions
Deductible Contributions Of Art	1	DeductibleContributionsOfArt
Terminated	0	Terminated
Partial Liquidation	0	PartialLiquidation
Disregarded Entity	0	DisregardedEntity
Related Entity	1	RelatedEntity
Related Org Controlled Entity	1	RelatedOrgControlledEntity
Transfers To Exempt Non Chrtbl Org	0	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	0	ActivitiesConductedPartnership
Schedule O Required	1	ScheduleORequired
Number Forms Transmitted With1096	2	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Number Of Employees	3074	NumberOfEmployees
Employment Tax Returns Filed	1	EmploymentTaxReturnsFiled
Unrelated Business Income	1	UnrelatedBusinessIncome
Form990-T Filed	1	Form990-TFiled
Foreign Financial Account	1	ForeignFinancialAccount
Name Of Foreign Country	CJ	NameOfForeignCountry
Name Of Foreign Country	UK	NameOfForeignCountry
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTrans
Taxable Party Notification	0	TaxablePartyNotification
Non Deductible Contributions	0	NonDeductibleContributions
Quid Pro Quo Contributions	1	QuidProQuoContributions
Quid Pro Quo Disclosure	1	QuidProQuoDisclosure
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOf
Funds To Pay Premiums	0	FundsToPayPremiums
Premiums Paid	0	PremiumsPaid
Nbr Voting Governing Body Members	20	NbrVotingGoverningBodyMembers
Number Independent Voting Members	19	NumberIndependentVotingMembers
Family Or Business Relationship	0	FamilyOrBusinessRelationship
Delegation Of Management Duties	0	DelegationOfManagementDuties
Changes To Organizing Docs	0	ChangesToOrganizingDocs
Material Diversion Or Misuse	0	MaterialDiversionOrMisuse
Members Or Stockholders	0	MembersOrStockholders
Election Of Board Members	0	ElectionOfBoardMembers
Decisions Subject To Approval	0	DecisionsSubjectToApproval
Minutes Of Governing Body	1	MinutesOfGoverningBody
Minutes Of Committees	1	MinutesOfCommittees
Officer Mailing Address	0	OfficerMailingAddress
Local Chapters	1	LocalChapters
Policies Reference Chapters	1	PoliciesReferenceChapters
Form990 Provided To Governing Body	1	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	1	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	1	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	1	RegularMonitoringEnforcement
Whistleblower Policy	1	WhistleblowerPolicy
Document Retention Policy	1	DocumentRetentionPolicy
Compensation Process CEO	1	CompensationProcessCEO
Compensation Process Other	1	CompensationProcessOther
Investment In Joint Venture	0	InvestmentInJointVenture
States Where Copy Of Return Is Filed	AK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AZ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	FL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	GA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	HI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	IL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MD	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ME	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ND	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NJ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NM	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	PA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	RI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	SC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	TN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	UT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WV	StatesWhereCopyOfReturnIsFiled
Upon Request	X	UponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	Fred Hutchinson Cancer Research Center	BusinessNameLine1
Business Name Line2	Randy Main	BusinessNameLine2

Field	Value	IRS element (for citing)
Telephone Number	2066674876	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	1100 Fairview Ave North	AddressLine1
Address Line2	J6-300	AddressLine2
City	Seattle	City
State	WA	State
ZIP Code	98109	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (47 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Individual Trustee Or DirectorIndividualTrusteeOrDirector	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation	OfficerOfficer	Key EmployeeKeyEmployee	Highest Compensated EmployeeHighestCompensatedEmployee	FormerFormer
Douglas Walker
Chair	10	X	0	0	0
Steve Davis
Vice Chair	5	X	0	0	0
Richard Ric Anderson
Trustee	1	X	0	0	0
Richard Begert
Trustee	1	X	0	0	0
Hollis Holly Dillon
Trustee	1	X	0	0	0
Karl Ege
Treasurer	4	X	0	0	0
Karen Glover
Trustee	1	X	0	0	0
Robert Herbold
Trustee	1	X	0	0	0
Peter Horvitz
Trustee	1	X	0	0	0
Henry James
Secretary	1	X	0	0	0
Richard Jones
Trustee	1	X	0	0	0
Don Listwin
Trustee	1	X	0	0	0
Richard McCune
Trustee	1	X	0	0	0
Karen Moyer
Trustee	1	X	0	0	0
Sally Narodick
Immediate Past Chair	2	X	0	0	0
Robert Nelson
Trustee	1	X	0	0	0
Peter Neupert
Trustee	1	X	0	0	0
James Sinegal
Trustee	1	X	0	0	0
Stephen Sundborg
Trustee	1	X	0	0	0
Douglas Williams
Trustee	2	X	0	0	0
Frederick R Appelbaum
Sr VP & Dir, Clin Res Div	40		484212	0	45952	X
Janell E Baldwin
VP Shared Resources	40		196776	0	31714	X
Jonathan Cooper
Sr VP & Dir, Basic Sci	40		222581	0	34271	X
Lawrence Corey
Sr VP & Co-Dir, VIDI	9		50802	0	0	X
Linda L Gainer
VP External Affairs & Comm	40		230965	0	38090	X
Mark T Groudine
Sr VP & Deputy Dir, FHCRC	40		425713	0	60097	X
Leland H Hartwell
President & Director	40		677547	0	44464	X
Randall C Main
VP & Chief Financial Officer	40		359400	0	44464	X
Ulrich W Mueller
VP Industry Rel & Tech Transfr	40		239198	0	48263	X
Howard Albert Nachtrieb
VP Human Resources	40		231816	0	46097	X
Ross L Prentice
Sr VP & Dir, PHS	40		389843	0	44452	X
Robert J Robbins
VP Information Tech	40		297038	0	24171	X
James M Roberts
Sr VP & Dir, Basic Sci	21		144840	0	31914	X
Scott N Rusch
VP Operations & Facilities	40		197114	0	36127	X
Douglas J Shaeffer
VP General Counsel	40		307478	0	43476	X
Myra H Tanita
Exec VP & COO	40		383916	0	45778	X
Barbara Trask
Sr VP & Dir, Human Biology	40		278736	0	56155	X
Nancy L Wells
VP and Dir of Development	40		411138	0	39778	X
Margaret Juliana McElrath
Full Member & Co-Dir, VIDI	40		232806	0	54976		X
Steven G Self
Full Member & Co-Dir, VIDI	40		266025	0	63947		X
Henry F Warden
Executive Director, VIDI	40		254050	0	36626			X
Samir M Hanash
Full Member	40		329629	0	43216			X
Martin A Cheever
Full Member	40		289396	0	39706			X
Charles N Petty
Staff Physician	40		265928	0	26633			X
Irwin D Bernstein
Full Member	40		263856	0	39551			X
F Marc Stewart
Medical Director, SCCA	40		151776	0	28530				X
Rainier F Storb
Full Member	40		247098	0	37999				X

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	7829677	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	0	TotalReportableCompFrmRltdOrgs
Total Other Compensation	1086447	TotalOtherCompensation
Number Individuals GT100 K	287	NumberIndividualsGT100K
Formers Listed	1	FormersListed
Total Comp GT150 K	1	TotalCompGT150K
Compensation From Other Sources	0	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation
W LEASE LEWIS COMPANY
See Schedule O	See Schedule O	WA	98104	Construction	2116530
SPAWA LLC
See Schedule O	See Schedule O	HI	96813	Security	633382
TOWNSEND AND TOWNSEND AND CREW LLP
See Schedule O	See Schedule O	CA	94111	Attorneys	610021
KPMG LLP
See Schedule O	See Schedule O	TX	75312	Auditing services	385080
WOODCOCK WASHBURN LLP
See Schedule O	See Schedule O	PA	19104	Attorneys	277354

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	287	NumberOfContractorsGT100K
Federated Campaigns	610903	FederatedCampaigns
Membership Dues	0	MembershipDues
Fundraising Events	10619145	FundraisingEvents
Related Organizations	0	RelatedOrganizations
Government Grants	289507107	GovernmentGrants
All Other Contributions	44593804	AllOtherContributions
Noncash Contributions	5182789	NoncashContributions
Total Contributions	345330959	TotalContributions

Program Service Revenue ProgramServiceRevenue (3 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome	ExclusionExclusionAmount
Research Activities	900099	11220474	11220474	$0
Interaffiliate Agreements and Services	900099	26108095	26108095	$0
Patient Services at SCCA	900099	7528336	7528336	$0

Total Oth Program Service Revenue TotalOthProgramServiceRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$0	ExclusionAmount

Field	Value	IRS element (for citing)
Total Program Service Revenue	44856905	TotalProgramServiceRevenue

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	4232082	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	-62064	UnrelatedBusinessRevenue
Exclusion	$4,294,146	ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

Field	Value	IRS element (for citing)
Total Revenue Column	88296	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$88,296	ExclusionAmount

Royalties Revenue RoyaltiesRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	9453968	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$9,453,968	ExclusionAmount

Gross Rents GrossRents

Field	Value	IRS element (for citing)
Real	3653655	Real
Personal	0	Personal

Less Rental Expenses LessRentalExpenses

Field	Value	IRS element (for citing)
Real	0	Real
Personal	0	Personal

Rental Income Or Loss RentalIncomeOrLoss

Field	Value	IRS element (for citing)
Real	3653655	Real
Personal	0	Personal

Net Rental Income Or Loss NetRentalIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	3653655	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$3,653,655	ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	44678000	Securities
Other	65709	Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	44522521	Securities
Other	0	Other

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	155479	Securities
Other	65709	Other

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	221188	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$221,188	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Income Fundraising Events	485918	GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events	10619145	CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses	805904	FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

Field	Value	IRS element (for citing)
Total Revenue Column	-319986	TotalRevenueColumn
Related Or Exempt Function Income	0	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	-$319,986	ExclusionAmount

Field	Value	IRS element (for citing)
Total Other Revenue	0	TotalOtherRevenue

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	407517067	TotalRevenueColumn
Related Or Exempt Function Income	44856905	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	-62064	UnrelatedBusinessRevenue
Exclusion	$17,391,267	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	55725117	Total
Program Services	55725117	ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	6781434	Total
Program Services	6781434	ProgramServices

Benefits To Members BenefitsToMembers

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

Field	Value	IRS element (for citing)
Total	6012964	Total
Program Services	3329922	ProgramServices
Management And General	2362751	ManagementAndGeneral
Fundraising	320291	Fundraising

Comp Disqual Persons CompDisqualPersons

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Other Salaries And Wages OtherSalariesAndWages

Field	Value	IRS element (for citing)
Total	157828011	Total
Program Services	129140913	ProgramServices
Management And General	25600190	ManagementAndGeneral
Fundraising	3086908	Fundraising

Pension Plan Contributions PensionPlanContributions

Field	Value	IRS element (for citing)
Total	11801678	Total
Program Services	9758452	ProgramServices
Management And General	1798753	ManagementAndGeneral
Fundraising	244473	Fundraising

Other Employee Benefits OtherEmployeeBenefits

Field	Value	IRS element (for citing)
Total	17449427	Total
Program Services	14314156	ProgramServices
Management And General	2804804	ManagementAndGeneral
Fundraising	330467	Fundraising

Payroll Taxes PayrollTaxes

Field	Value	IRS element (for citing)
Total	12170514	Total
Program Services	9930198	ProgramServices
Management And General	1997525	ManagementAndGeneral
Fundraising	242791	Fundraising

Fees For Services Management FeesForServicesManagement

Field	Value	IRS element (for citing)
Total	83164	Total
Program Services	0	ProgramServices
Management And General	83164	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	810577	Total
Program Services	0	ProgramServices
Management And General	810577	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	406865	Total
Program Services	0	ProgramServices
Management And General	406865	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Lobbying FeesForServicesLobbying

Field	Value	IRS element (for citing)
Total	112213	Total
Program Services	0	ProgramServices
Management And General	112213	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	88717	Total
Fundraising	88717	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	575291	Total
Program Services	0	ProgramServices
Management And General	575291	ManagementAndGeneral
Fundraising	0	Fundraising

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	19061856	Total
Program Services	11346410	ProgramServices
Management And General	7317913	ManagementAndGeneral
Fundraising	397533	Fundraising

Advertising Advertising

Field	Value	IRS element (for citing)
Total	253059	Total
Program Services	0	ProgramServices
Management And General	156626	ManagementAndGeneral
Fundraising	96433	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	4887580	Total
Program Services	873934	ProgramServices
Management And General	3442474	ManagementAndGeneral
Fundraising	571172	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	434426	Total
Program Services	0	ProgramServices
Management And General	434426	ManagementAndGeneral
Fundraising	0	Fundraising

Royalties Royalties

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	7652495	Total
Program Services	107456	ProgramServices
Management And General	7545039	ManagementAndGeneral
Fundraising	0	Fundraising

Travel Travel

Field	Value	IRS element (for citing)
Total	2074936	Total
Program Services	1774485	ProgramServices
Management And General	206178	ManagementAndGeneral
Fundraising	94273	Fundraising

Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	564438	Total
Program Services	507867	ProgramServices
Management And General	36690	ManagementAndGeneral
Fundraising	19881	Fundraising

Interest Interest

Field	Value	IRS element (for citing)
Total	12096505	Total
Program Services	11243750	ProgramServices
Management And General	852755	ManagementAndGeneral
Fundraising	0	Fundraising

Payments To Affiliates PaymentsToAffiliates

Field	Value	IRS element (for citing)
Total	0	Total
Program Services	0	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	0	Fundraising

Depreciation Depletion DepreciationDepletion

Field	Value	IRS element (for citing)
Total	25142325	Total
Program Services	22208008	ProgramServices
Management And General	2934317	ManagementAndGeneral
Fundraising	0	Fundraising

Insurance Insurance

Field	Value	IRS element (for citing)
Total	1570569	Total
Program Services	0	ProgramServices
Management And General	1570569	ManagementAndGeneral
Fundraising	0	Fundraising

Other Expenses OtherExpenses (3 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
Research Supplies	23859197	23859197	0	0
Equipment rental & maintenance	9715099	2572219	7108526	34354
Allocation of indirect costs	0	52186998	-52186998

All Other Expenses AllOtherExpenses

Field	Value	IRS element (for citing)
Total	11480766	Total
Program Services	8608843	ProgramServices
Management And General	2534605	ManagementAndGeneral
Fundraising	337318	Fundraising

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	388639223	Total
Program Services	364269359	ProgramServices
Management And General	18505253	ManagementAndGeneral
Fundraising	5864611	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	24533	BOY
EOY	15274	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	8187666	BOY
EOY	35926246	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	25998943	BOY
EOY	32217752	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	19971787	BOY
EOY	18479708	EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

Field	Value	IRS element (for citing)
BOY	818124	BOY
EOY	695757	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	1003720	BOY
EOY	1164713	EOY

Field	Value	IRS element (for citing)
Land Buildings Equipment Basis	544237673	LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec	279058688	LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

Field	Value	IRS element (for citing)
BOY	278986702	BOY
EOY	265178985	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	51491607	BOY
EOY	58983024	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	45929469	BOY
EOY	48090908	EOY

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
BOY	52255695	BOY
EOY	59784031	EOY

Intangible Assets IntangibleAssets

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	33841462	BOY
EOY	35261915	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	518509708	BOY
EOY	555798313	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	28615888	BOY
EOY	38025954	EOY

Grants Payable GrantsPayable

Field	Value	IRS element (for citing)
BOY	0	BOY
EOY	0	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	27593897	BOY
EOY	29178432	EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

Field	Value	IRS element (for citing)
BOY	265770906	BOY
EOY	266607522	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	21899309	BOY
EOY	28981141	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	343880000	BOY
EOY	362793049	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	107049708	BOY
EOY	114011264	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	24364000	BOY
EOY	32312000	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	43216000	BOY
EOY	46682000	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	174629708	BOY
EOY	193005264	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	518509708	BOY
EOY	555798313	EOY

Field	Value	IRS element (for citing)
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	0	AccountantCompileOrReview
FS Audited	1	FSAudited
Audit Committee	1	AuditCommittee
Financial Statement Separate	X	FinancialStatementSeparate
Federal Grant Audit Required	1	FederalGrantAuditRequired
Federal Grant Audit Performed	1	FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org170b1 Avi	X	PubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	278743884	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	301287235	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	322118651	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	309139679	CurrentTaxYearMinus1Year
Current Tax Year	345010973	CurrentTaxYear
Total	1556300422	Total

Tax Rev Levied For Org Benefit170 TaxRevLeviedForOrgBenefit170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	0	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	0	CurrentTaxYearMinus1Year
Current Tax Year	0	CurrentTaxYear
Total	0	Total

Value Srvc Fclts Furnished By Govt ValueSrvcFcltsFurnishedByGovt

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	0	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	0	CurrentTaxYearMinus1Year
Current Tax Year	0	CurrentTaxYear
Total	0	Total

Total170 Total170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	278743884	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	301287235	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	322118651	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	309139679	CurrentTaxYearMinus1Year
Current Tax Year	345010973	CurrentTaxYear
Total	1556300422	Total

Field	Value	IRS element (for citing)
Amounts Subst Contributors Total	0	AmountsSubstContributorsTotal
Public Support Total170	1556300422	PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	14001069	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	19279966	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	20511518	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	6696878	CurrentTaxYearMinus1Year
Current Tax Year	17583481	CurrentTaxYear
Total	78072912	Total

Net UBI NetUBI

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	18779	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	-38843	CurrentTaxYearMinus1Year
Current Tax Year	-62064	CurrentTaxYear
Total	-82128	Total

Other Income170 OtherIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	0	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	0	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	0	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	0	CurrentTaxYearMinus1Year
Current Tax Year	0	CurrentTaxYear
Total	0	Total

Field	Value	IRS element (for citing)
Total Support	1634291206	TotalSupport
Public Support Pertcentage170	0.95228	PublicSupportPertcentage170
Public Support Pertcent Prior Year	0.95654	PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170	X	ThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Total Direct Lobbying TotalDirectLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	112213	FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	112213	FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	387951719	FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	388063932	FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	1000000	FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	250000	FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	1000000	CurrentYearMinus3
Current Year Minus2	1000000	CurrentYearMinus2
Current Year Minus1	1000000	CurrentYearMinus1
Current Year	1000000	CurrentYear
Total	4000000	Total

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

Field	Value	IRS element (for citing)
Current Year Minus3	147387	CurrentYearMinus3
Current Year Minus2	118116	CurrentYearMinus2
Current Year Minus1	106714	CurrentYearMinus1
Current Year	112213	CurrentYear
Total	484430	Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	250000	CurrentYearMinus3
Current Year Minus2	250000	CurrentYearMinus2
Current Year Minus1	250000	CurrentYearMinus1
Current Year	250000	CurrentYear
Total	1000000	Total

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

Field	Value	IRS element (for citing)
Current Year Minus3	0	CurrentYearMinus3
Current Year Minus2	0	CurrentYearMinus2
Current Year Minus1	0	CurrentYearMinus1
Current Year	0	CurrentYear
Total	0	Total

Schedule D IRS990ScheduleD

Art Public Exhibition Amts ArtPublicExhibitionAmts

Field	Value	IRS element (for citing)
Revenues Included	610903	RevenuesIncluded
Assets In Part X	555798313	AssetsInPartX

Held Works Of Art Amts HeldWorksOfArtAmts

Field	Value	IRS element (for citing)
Revenues Included	710646	RevenuesIncluded
Assets In Part X	710646	AssetsInPartX

Field	Value	IRS element (for citing)
Collect Used For Public Exhibition	X	CollectUsedForPublicExhibition

Collection Used For Other CollectionUsedForOther

Field	Value	IRS element (for citing)
Collection Used For Other Purposes	X	CollectionUsedForOtherPurposes
Description Of Other Purposes	See the explanation for Ln 3e.	DescriptionOfOtherPurposes

Field	Value	IRS element (for citing)
Solicited Assets For Sale	0	SolicitedAssetsForSale

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	75830000	BeginningOfYearBalance
Contributions	5559524	Contributions
Investment Earnings Or Losses	7831043	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	7218860	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	82001707	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	100751000	BeginningOfYearBalance
Contributions	4053000	Contributions
Investment Earnings Or Losses	-18913000	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	10061000	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	75830000	EndOfYearBalance

Field	Value	IRS element (for citing)
Board Designated EOY Balance	0.68	BoardDesignatedEOYBalance
Permanent Endowment EOY Balance	0.27	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.05	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	0	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	0	EndowmentsHeldByRelatedOrgs

Land Land

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	42355609	OtherCostOrOtherBasis
Book Value	42355609	BookValue

Buildings Buildings

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	346859212	OtherCostOrOtherBasis
Depreciation	201794472	Depreciation
Book Value	145064740	BookValue

Leasehold Improvements LeaseholdImprovements

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	0	OtherCostOrOtherBasis
Depreciation	0	Depreciation
Book Value	0	BookValue

Equipment Equipment

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	152855218	OtherCostOrOtherBasis
Depreciation	77264216	Depreciation
Book Value	75591002	BookValue

Other Land Buildings OtherLandBuildings

Field	Value	IRS element (for citing)
Investment Cost Or Other Basis	0	InvestmentCostOrOtherBasis
Other Cost Or Other Basis	2167634	OtherCostOrOtherBasis
Depreciation	0	Depreciation
Book Value	2167634	BookValue

Field	Value	IRS element (for citing)
Total Of Book Value Land Buildings	265178985	TotalOfBookValueLandBuildings

Other Securities OtherSecurities (7 entries)

DescriptionDescription	Book ValueBookValue	Method Of ValuationMethodOfValuation
MORTGAGE-BACKED SECURITIES	1757572	F
COLLATERIZED MORTGAGE OBLIG	389780	F
ASSET BACKED SECURITIES	148438	F
HEDGE FUND	14908629	F
LIMITED PARTNERSHIPS	23648305	F
IKARIA STOCK	6411001	F
OTHER	827183	F

Field	Value	IRS element (for citing)
Total Of Book Value Securities	48090908	TotalOfBookValueSecurities

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
Description	INVESTMENT IN SEATTLE CANCER CARE ALLIANCE	Description
Book Value	59784031	BookValue
Method Of Valuation	C	MethodOfValuation

Field	Value	IRS element (for citing)
Total Of Book Value Program Related	59784031	TotalOfBookValueProgramRelated

Other Assets OtherAssets (4 entries)

DescriptionDescription	Book ValueBookValue
BENEFICIAL INTEREST IN PERPETUAL TRUSTS	23985122
RENTAL PROPERTY	9227629
DEFERRED FINANCING COSTS	2048161
OTHER ASSETS	1003

Field	Value	IRS element (for citing)
Total Book Value Other Assets	35261915	TotalBookValueOtherAssets
Federal Income Tax Liability	0	FederalIncomeTaxLiability

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
Description	Deferred Credit Cash Flow Hedge	Description
Amount	$28,981,141	Amount

Field	Value	IRS element (for citing)
Total Of Amounts	28981141	TotalOfAmounts
Total Revenue	407517067	TotalRevenue
Total Expenses	388639223	TotalExpenses
Excess Or Deficit For Year	18877844	ExcessOrDeficitForYear
Net Unrealized GL On Investments	6574622	NetUnrealizedGLOnInvestments
Donated Services And Facilities	0	DonatedServicesAndFacilities
Investment Expenses	0	InvestmentExpenses
Prior Period Adjustments	0	PriorPeriodAdjustments
Other	-$7,078,202	OtherAmount
Total Adjustments	-503580	TotalAdjustments
Excess Or Deficit Per FS	18374264	ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt	406941776	TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments	0	NetUnrealizedGainsInvestments
Donated Srvc And Use Of Facilities	0	DonatedSrvcAndUseOfFacilities
Recoveries Of Prior Year Grants	0	RecoveriesOfPriorYearGrants
Other Revenues	0	OtherRevenues
Revenue Not Rptd F990	0	RevenueNotRptdF990
Revenue Subtotal	406941776	RevenueSubtotal
Investment Expenses Not Included	575291	InvestmentExpensesNotIncluded
Other Revenues Not Included	0	OtherRevenuesNotIncluded
Revenue Not Rptd On Fin Stmt	575291	RevenueNotRptdOnFinStmt
Total Revenue Per Form990	407517067	TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt	388063932	TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities	0	DonatedServicesUseOfFacilities
Prior Year Adjustments	0	PriorYearAdjustments
Losses Reported	0	LossesReported
Other Expenses Included	0	OtherExpensesIncluded
Expenses Not Rptd F990	0	ExpensesNotRptdF990
Expenses Subtotal	388063932	ExpensesSubtotal
Investment Expenses Not Included2	575291	InvestmentExpensesNotIncluded2
Other Expenses Not Included	0	OtherExpensesNotIncluded
Expenses Not Rptd On Fin Stmt	575291	ExpensesNotRptdOnFinStmt
Total Expenses Per Form990	388639223	TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (5 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchD_P03_S00_L03e	Schedule D, Part III, Line 3e	Per donor restriction, must maintain until 2030.
SchD_P03_S00_L04	Schedule D, Part III, Line 4	The QTIP Trust of the 1993 Kullman Family Trust donated to the Center a collection of forty black and white photographs with an appraised value of $710,646. The Artwork Donation Agreement requires the Center to display the Artwork as a collection at its main campus in Seattle, Washington for at least twenty years. The Artwork Donation Agreement states that "the Center shall have the right to use and display the Artwork in the manner that best serves the interest of the Center." At the end of the required twenty year display period, the Center will determine if opportunities exist that may allow the value of the donated artwork to fund the Center's research.
SchD_P05_S00_L04	Schedule D, Part V, Line 4	Spending Policy The Center's spending policy for endowment funds is to appropriate for distribution each year 5% percent of the endowment fund's average fair value over the prior three years, provided that the fair value of the endowment fund exceeds the corpus. For a portion of the Center's Board-designated investments, the Center does not appropriate for distribution any amount of investment return as all of the return earned is held to grow the fund for future repayment of long-term debt. For the remaining board designated investments, the Center makes all investment return available for expenditure on programmatic initiatives. In establishing these policies, the Center considered the long-term expected returns on its endowment and Board-designated investments.
SchD_P10_S00_L00	Schedule D, Part X	N/A.
SchD_P11_S00_L08	Schedule D, Part XI, Line 8	Change in net unrealized value of swap instruments.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	1	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (7 entries)

RegionRegion	Number Of EmployeesNumberOfEmployees	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
Central America and the Caribbean	0	Grantmaking	N/A	537313
East Asia and the Pacific	0	Grantmaking	N/A	1915073
Europe (including Iceland and Greenland)	0	Grantmaking	N/A	264042
North America (including Canada and Mexico, but not the United States)	0	Grantmaking	N/A	687470
South America	0	Grantmaking	N/A	599326
Sub-Saharan Africa	0	Grantmaking	N/A	1866017
Sub-Saharan Africa	1	Program Services	Research	79744

Field	Value	IRS element (for citing)
Total Number Of Offices	0	TotalNumberOfOffices
Total Number Of Employees	1	TotalNumberOfEmployees
Total Amount Spent	5948985	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (26 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Method Of ValuationMethodOfValuation
Central America and the Caribbean	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	381998	Wire transfer	N/A	N/A
Central America and the Caribbean	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	155315	Wire transfer	N/A	N/A
East Asia and the Pacific	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	17000	Check	N/A	N/A
East Asia and the Pacific	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	1898073	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	BREAST HEALTH GLOBAL INITIATIVE	10000	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	CORE ASSASYS MRLI - W1, W3	19817	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: HIV PR	118872	Wire transfer	N/A	N/A
Europe (including Iceland and Greenland)	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	115353	Wire transfer	N/A	N/A
North America (including Canada and Mexico, but not the United States)	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA	16474	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	HEPATITIS B ESL EDUCATION FOR CHINESE	28999	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	HEPATITIS B ESL EDUCATION FOR CHINESE	5386	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	17829	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE	303916	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOM	39608	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOM	38035	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION	78326	Check	N/A	N/A
North America (including Canada and Mexico, but not the United States)	WASHINGTON VACCINE ALLIANCE	158896	Check	N/A	N/A
South America	BREAST HEALTH GLOBAL INITIATIVE	12458	Wire transfer	N/A	N/A
South America	IMPROVING BREAST CANCER SCREENING AT THE PRIMARY CARE LE	12037	Wire transfer	N/A	N/A
South America	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	314548	Wire transfer	N/A	N/A
South America	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	260283	Wire transfer	N/A	N/A
Sub-Saharan Africa	HVTN LABORATORY PROGRAM	238421	Wire transfer	N/A	N/A
Sub-Saharan Africa	HVTN LABORATORY PROGRAM	517581	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	263019	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	610743	Wire transfer	N/A	N/A
Sub-Saharan Africa	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	236253	Wire transfer	N/A	N/A

Field	Value	IRS element (for citing)
Total Number Of501c3 Orgs	1	TotalNumberOf501c3Orgs
Total Number Of Other Orgs	20	TotalNumberOfOtherOrgs

Grants To Ind Outside US GrantsToIndOutsideUS (19 entries)

Type Of AssistanceTypeOfAssistance	RegionRegion	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Method Of ValuationMethodOfValuation
Airfare	Central America and the Caribbean	1	1648	Check	N/A	N/A
Airfare	East Asia and the Pacific	1	59986	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	East Asia and the Pacific	1	75791	Check	N/A	N/A
Airfare	Europe (including Iceland and Greenland)	1	256963	Check	N/A	N/A
Airfare	Europe (including Iceland and Greenland)	1	3228	Wire	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Europe (including Iceland and Greenland)	1	119218	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Europe (including Iceland and Greenland)	1	2422	Wire	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Middle East and North Africa	1	6394	Check	N/A	N/A
Airfare	North America (including Canada and Mexico, but not the United States)	1	15551	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	North America (including Canada and Mexico, but not the United States)	1	6329	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	North America (including Canada and Mexico, but not the United States)	1	446	Wire	N/A	N/A
Airfare	Russia and the newly independent States	1	8499	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Russia and the newly independent States	1	10963	Check	N/A	N/A
Airfare	South America	1	1233	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	South America	1	10700	Check	N/A	N/A
Airfare	Sub-Saharan Africa	1	188843	Check	N/A	N/A
Airfare	Sub-Saharan Africa	1	279	Wire	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Sub-Saharan Africa	1	60186	Check	N/A	N/A
Travel costs (e.g. lodging, meals, incidentals, etc.)	Sub-Saharan Africa	1	3769	Wire	N/A	N/A

Form990 Schedule F Part IV Form990ScheduleFPartIV (2 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchF_P01_S00_L02	Schedule F, Part I, Line 2	Schedule F, Part I, Line 2 - Procedure for Monitoring the Use of Grant Funds Once the notice of award has been received and the Center project ID activated, the subaward can be set up. The structure of the subaward will depend on how the Prime is set up. Generally at the Center, a new PO is requisitioned for each subaward for each year of a project. This allows the RC to closely monitor subaward invoices and encumbrances. For our Subrecipients, it means a separate budget ID and final invoice each year. Carryover between years is not automatic. There are 5 primary steps. 1) Step one is within OSR. The Grant Specialist notifies the Contract Specialist that a grant which includes a subaward has been funded, and provides to the Contract Specialist a copy of the award, the signed subaward application (if available) and any special instructions. A signed subaward application is important because it shows that the Subrecipient organization has reviewed and approved the budget and scope of work. 2) The Research Coordinator (RC) sends the Contract Specialist a Subcontract Acquisition Form (SAF). This form provides authorization for the Contract Specialist to issue the subaward, and included a scope of work, budget and pertinent subrecipient information. It is necessary to provide the scope of work and budget on the SAF as these items may have changed from what was originally submitted in the subaward application. 3) The Contract Specialist requisitions the subaward PO, which the RC must approve. An e-mail is sent to the RC notifying them that the requisition is pending and requires approval. Because OSR does not have funds commitment authority the RC is required to approve all requisition. 4) OSR collects information required to correctly set up the subaward. These items include IRO and IACUC approval dates, confirmation of subaward F&A rates and A-133 Audit reports, review of Prime special terms and conditions to determine flow-down, confirmation that the Subrecipients is not debarred, and other similar regulatory and administrative requirements. While much of this information is collected by OSR, the RC may, in addition to completing the SAF, be asked to assist in the collection of some of the documentation. 5) OSR writes the subaward agreement, and mails it to the Subrecipients for signature. Some agreements can be signed by OSR before mailing, while others will be sent unsigned. This is determined by the Contract Specialist based on the terms of award and status of administrative and regulatory requirements. A copy of the initial subaward is sent to the RC. Once the subaward has been fully signed, a copy is sent to the RC for their files. No invoices should be approved by the RC until they have received a fully executed agreement.
SchF_P03_S00_L00	Schedule F, Part III	(1) The data presented is employee incurred foreign travel costs which we believe meet the IRS Schedule F, Part III's request for grants and other assistance to "U.S. individuals for foreign activity." As such, column (c)'s request for "the number of recipients that received the type of assistance in that region" does not appear to apply foreign travel cost incurred by U.S. individuals. The accrual method of accounting was used to prepare the form 990 and the organization's financial statements.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
Phone Solicitations	X	PhoneSolicitations
In Person Solicitations	X	InPersonSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Solicitation Of Govt Grants	X	SolicitationOfGovtGrants
Special Fundraising Events	X	SpecialFundraisingEvents
Agreement Ref Fundraising	1	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation (2 entries)

ActivityActivity	Fundraiser Control Of FundsFundraiserControlOfFunds	Gross ReceiptsGrossReceipts	Amount Retained By ContractorAmountRetainedByContractor	Net To OrganizationNetToOrganization
Lewis Kennedy Associates Inc
Direct Mail	0	613882	68718	545164
DirectLine Technologies Inc
Tele-Marketing	0	33606	20000	13606

Field	Value	IRS element (for citing)
Total Gross Receipts	647488	TotalGrossReceipts
Total Retained By Contractors	88718	TotalRetainedByContractors
Total Net To Organization	558770	TotalNetToOrganization
Licensed States	AK	LicensedStates
Licensed States	AL	LicensedStates
Licensed States	AR	LicensedStates
Licensed States	AZ	LicensedStates
Licensed States	CA	LicensedStates
Licensed States	CO	LicensedStates
Licensed States	CT	LicensedStates
Licensed States	FL	LicensedStates
Licensed States	GA	LicensedStates
Licensed States	HI	LicensedStates
Licensed States	IL	LicensedStates
Licensed States	KS	LicensedStates
Licensed States	KY	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	MD	LicensedStates
Licensed States	ME	LicensedStates
Licensed States	MI	LicensedStates
Licensed States	MN	LicensedStates
Licensed States	MO	LicensedStates
Licensed States	MS	LicensedStates
Licensed States	NC	LicensedStates
Licensed States	ND	LicensedStates
Licensed States	NH	LicensedStates
Licensed States	NJ	LicensedStates
Licensed States	NM	LicensedStates
Licensed States	NY	LicensedStates
Licensed States	OH	LicensedStates
Licensed States	OK	LicensedStates
Licensed States	OR	LicensedStates
Licensed States	PA	LicensedStates
Licensed States	RI	LicensedStates
Licensed States	SC	LicensedStates
Licensed States	TN	LicensedStates
Licensed States	UT	LicensedStates
Licensed States	VA	LicensedStates
Licensed States	WA	LicensedStates
Licensed States	WI	LicensedStates
Licensed States	WV	LicensedStates

Events Information EventsInformation

Field	Value	IRS element (for citing)
Name Of Event1	See Schedule O	NameOfEvent1
Gross Receipts Event1	9544928	GrossReceiptsEvent1
Charitable Contributions Event1	9220928	CharitableContributionsEvent1
Gross Revenue Event1	324000	GrossRevenueEvent1
Cash Prizes Event1	0	CashPrizesEvent1
Non Cash Prizes Event1	0	NonCashPrizesEvent1
Rent Facility Costs Event1	0	RentFacilityCostsEvent1
Food And Beverage Event1	136684	FoodAndBeverageEvent1
Entertainment Event1	6000	EntertainmentEvent1
Other Direct Expenses Event1	182139	OtherDirectExpensesEvent1
Name Of Event2	See Schedule O	NameOfEvent2
Gross Receipts Event2	593429	GrossReceiptsEvent2
Charitable Contributions Event2	593429	CharitableContributionsEvent2
Gross Revenue Event2	0	GrossRevenueEvent2
Cash Prizes Event2	0	CashPrizesEvent2
Non Cash Prizes Event2	0	NonCashPrizesEvent2
Rent Facility Costs Event2	0	RentFacilityCostsEvent2
Food And Beverage Event2	0	FoodAndBeverageEvent2
Entertainment Event2	0	EntertainmentEvent2
Other Direct Expenses Event2	230744	OtherDirectExpensesEvent2
Total Number Of Other Events	6	TotalNumberOfOtherEvents
Gross Receipts Other Events	966706	GrossReceiptsOtherEvents
Charitable Contrib Other Events	804788	CharitableContribOtherEvents
Gross Revenue Other Events	161918	GrossRevenueOtherEvents
Cash Prizes Other Events	0	CashPrizesOtherEvents
Non Cash Prizes Other Events	0	NonCashPrizesOtherEvents
Rent Facility Costs Other Events	0	RentFacilityCostsOtherEvents
Food And Beverage Other Events	73414	FoodAndBeverageOtherEvents
Entertainment Other Events	2500	EntertainmentOtherEvents
Other Direct Expenses Other Events	174423	OtherDirectExpensesOtherEvents
Gross Receipts Total	11105063	GrossReceiptsTotal
Charitable Contributions Total	10619145	CharitableContributionsTotal
Gross Revenue Total Events	485918	GrossRevenueTotalEvents
Cash Prizes Total Events	0	CashPrizesTotalEvents
Non Cash Prizes Total Events	0	NonCashPrizesTotalEvents
Rent Facility Costs Total Events	0	RentFacilityCostsTotalEvents
Food And Beverage Total Events	210098	FoodAndBeverageTotalEvents
Entertainment Total Events	8500	EntertainmentTotalEvents
Other Direct Expenses Total Events	587306	OtherDirectExpensesTotalEvents
Direct Expense Summary Events	805904	DirectExpenseSummaryEvents
Net Income Summary	-319986	NetIncomeSummary

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	1	RecordsMaintained

Recipient Table RecipientTable (265 entries)

Address Line1AddressUS/AddressLine1	Address Line2AddressUS/AddressLine2	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Amount Of Non Cash AssistanceAmountOfNonCashAssistance	Method Of ValuationMethodOfValuation	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Purpose Of GrantPurposeOfGrant	Business Name Line2RecipientNameBusiness/BusinessNameLine2
AIDS RESEARCH ALLIANCE OF AMERICA
1400 S GRAND AVE	SUITE 701	LOS ANGELES	CA	90015	954264845	501(c)(3)	640988	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
4000 AMBASSADOR DRIVE		ANCHORAGE	AK	99508	920162721	501(c)(3)	98791	0	N/A	N/A	CANCER INFORMATION SERVICE: BASE PARTNERSHIP PROGRAM NW	ATTN OFFICE OF FINANCE and ADMINISTRATION
BASTYR UNIVERSITY
14500 JUANITA DRIVE NE		KENMORE	WA	98028	911036794	501(c)(3)	7731	0	N/A	N/A	USE OF COUNTER-INDICATED CAM TREATMENTS BY OVARIAN CANCE	FINANCE OFFICE
BATTELLE MEMORIAL INSTITUTE
P O BOX 999		RICHLAND	WA	99352	314379427	501(c)(3)	30910	0	N/A	N/A	THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES	PACIFIC NW NATIONAL LABORATORY
BATTELLE MEMORIAL INSTITUTE
P O BOX 84262		SEATTLE	WA	981245562	314379427	501(c)(3)	27153	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS	ATTN CASHIER
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZA	BCM 206	HOUSTON	TX	77030	741613878	501(c)(3)	62868	0	N/A	N/A	CORE ASSASYS MRLI - W1 W3	OFFICE OF GRANTS and CONTRACTS
BECKMAN RESEARCH INSTITUTE OF THE
1500 EAST DUARTE ROAD		DUARTE	CA	910103012	953432210	501(c)(3)	146119	0	N/A	N/A	TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMOR
BENAROYA RESEARCH INSTITUTE
1201 NINTH AVE		SEATTLE	WA	98101	910653422	501(c)(3)	19412	0	N/A	N/A	MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	45395	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	174127	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
BOARD OF TRUSTEES OF THE LELAND
P O BOX 44253		SAN FRANCISCO	CA	941444253	941156365	501(c)(3)	8135	0	N/A	N/A	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS
P O BOX 20787		SPRINGFIELD	IL	627080787	376000511	University	6661	0	N/A	N/A	PROSPECTIVE STUDY ON SELENIUM GENETICS OF SELENOENZYMES	GRANTS and CONTRACTS
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887		BOSTON	MA	022413887	042312909	501(c)(3)	1543416	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	BANK OF AMERICA FINANCE
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887		BOSTON	MA	022413887	042312909	501(c)(3)	122183	0	N/A	N/A	BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS	BANK OF AMERICA FINANCE
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887		BOSTON	MA	022413887	042312909	501(c)(3)	6748	0	N/A	N/A	BARRETT'S ESOPHAGUS: PREDICTORS OF PROGRESSION	BANK OF AMERICA FINANCE
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887		BOSTON	MA	022413887	042312909	501(c)(3)	48056	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	BANK OF AMERICA FINANCE
BRIGHAM AND WOMENS HOSPITAL INC
P O BOX 3887		BOSTON	MA	022413887	042312909	501(c)(3)	94341	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C	BANK OF AMERICA FINANCE
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER		CAMBRIDGE	MA	02142	263428781	501(c)(3)	133879	0	N/A	N/A	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C	CASH MANAGER OFFICE 7112L
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER		CAMBRIDGE	MA	02142	263428781	501(c)(3)	28406	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C	CASH MANAGER OFFICE 7112L
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE	SUITE 1900	SEATTLE	WA	981011468	911828539	501(c)(3)	1910121	0	N/A	N/A	SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE	SUITE 1900	SEATTLE	WA	981011468	911828539	501(c)(3)	1225707	0	N/A	N/A	SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE	SUITE 1900	SEATTLE	WA	981011468	911828539	501(c)(3)	15803	0	N/A	N/A	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
CEDARS SINAI MEDICAL CENTER
8700 BEVERLY BOULEVARD		LOS ANGELES	CA	900481865	951644600	501(c)(3)	21380	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	GRANT and CONTRACT SERVICES
CEDARS SINAI MEDICAL CENTER
8700 BEVERLY BLVD SUITE 1150	65-WIL	LOS ANGELES	CA	900481865	951644600	501(c)(3)	89816	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	SPONSORED RESEARCH and FUNDS ADMINISTRATION
CENTER FOR MEDICAL TECHNOLOGY POLICY
401 EAST PRATT STREET	SUITE 631	BALTIMORE	MD	21202	261409553	501(c)(3)	212692	0	N/A	N/A	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER	WORLD TRADE CENTER BALTIMORE
CHILDRENS HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE		CINCINNATI	OH	45229	310834008	501(c)(3)	129150	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION
CHILDRENS MEMORIAL HOSPITAL
2300 CHILDRENS PLAZA	BOX 205	CHICAGO	IL	60614	362170833	501(c)(3)	6481	0	N/A	N/A	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC	OFFICE OF SPONSORED PROGRAMS
CITY AND COUNTY OF SAN FRANCISCO
1380 HOWARD ST	RM 417	SAN FRANCISCO	CA	94103	946000417	Dept of Pub Health	184650	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
COLORADO STATE UNIVERSITY
CASHIERS OFFICE		FORT COLLINS	CO	805236015	846000545	University	229124	0	N/A	N/A	TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION	6015 CAMPUS DELIVERY - OSP
COMSYS INFO TECHNOLOGY SERVICES INC
P O BOX 60260		CHARLOTTE	NC	28260	751300240		210518	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMENS HEALTH INIT
CORNELL UNIVERSITY
P O BOX 22		ITHACA	NY	148510022	150532082	501(c)(3)	55763	0	N/A	N/A	TOWARDS A MODEL OF FANCONI ANEMIA
DANA FARBER CANCER INSTITUTE
44 BINNEY STREET	MAIL STOP BP451	BOSTON	MA	02115	042263040	501(c)(3)	73305	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	RESEARCH ACCOUNTING
DUKE UNIVERSITY
2200 WEST MAIN STREET	SUITE 300	DURHAM	NC	277054677	560532129	501(c)(3)	1255198	0	N/A	N/A	HVTN LABORATORY PROGRAM	OFFICE OF SPONSORED PROGRAMS
DUKE UNIVERSITY
2200 WEST MAIN STREET	SUITE 300	DURHAM	NC	277054677	560532129	501(c)(3)	131954	0	N/A	N/A	MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI	OFFICE OF SPONSORED PROGRAMS
EMORY UNIVERSITY
1599 CLIFTON ROAD NE	4TH FLOOR MS 1599-001-1BH	ATLANTA	GA	303224250	580566256	501(c)(3)	58601	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	GRANTS and CONTRACTS ACCOUNTING
EMORY UNIVERSITY
1599 CLIFTON ROAD NE	4TH FLOOR MS 1599-001-1BH	ATLANTA	GA	303224250	580566256	501(c)(3)	447597	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	GRANTS and CONTRACTS ACCOUNTING
EMORY UNIVERSITY
1599 CLIFTON ROAD NE	4TH FLOOR MS 1599-001-1BH	ATLANTA	GA	303224250	580566256	501(c)(3)	92207	0	N/A	N/A	CONTAINING BIOTERRORISM AND EMERGING INFECTIOUS DISEASES	GRANTS and CONTRACTS ACCOUNTING
EXPONENT INC
P O BOX 200283	DEPT 002	DALLAS	TX	753200283	770218904		7500	0	N/A	N/A	THE FEASIBILITY OF EARLIER DETECTION OF OVARIAN CANCER U
FENWAY COMMUNITY HEALTH
1340 BOYLSTON ST	9TH FLOOR	BOSTON	MA	02215	042510564	501(c)(3)	321432	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	FINANCE
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	40961	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HVTN
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	12455	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: HIV PR
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	35643	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: MICRO
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027		BOSTON	MA	022983027	161056814	501(c)(3)	131948	0	N/A	N/A	HPTN NETWORK STATISTICAL AND DATA MANAGEMENT OPERATIONS
GENERAL HOSPITAL CORPORATION DBA
P O BOX 414876		BOSTON	MA	022414876	042697983	501(c)(3)	176128	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F	RESEARCH FINANCE
GENERAL HOSPITAL CORPORATION DBA
P O BOX 3829		BOSTON	MA	022413829	042697983	501(c)(3)	28013	0	N/A	N/A	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C	RESEARCH FINANCE BANK OF AMERICA NA
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	132199	0	N/A	N/A	COLON CANCER PATHWAYS: HYPERPLASTICS POLYPS AND ADENOMA
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	24190	0	N/A	N/A	GENE COPY NUMBER CHANGES AND BREAST CANCER SURVIVAL
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	10540	0	N/A	N/A	MODELING US PROSTATE CANCER TRENDS: PSA TREATMENT and RAC
GROUP HEALTH COOPERATIVE
P O BOX 34587		SEATTLE	WA	981249990	910511770	501(c)(3)	76030	0	N/A	N/A	PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING IN M
HARBORVIEW MEDICAL CENTER
325 NINTH AVE	BOX 359750	SEATTLE	WA	98104	911631806	County Med Ctr	55703	0	N/A	N/A	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
HEMATOLOGICS INC
P O BOX 34936	DEPT 1023	SEATTLE	WA	98124	911685196	OTHER	11500	0	N/A	N/A	MOLECULAR ASSESSMENT OF MINIMAL RISK DISEASE IN ACUTE PR
HEMATOLOGICS INC
P O BOX 338		HOBART	WA	980250338	911685196	OTHER	188289	0	N/A	N/A	BIOMARKERS FOR RISK IDENTIFICATION AND RISK-BASED THERAP
HENRY M JACKSON FOUNDATION FOR THE
1401 ROCKVILLE PIKE SUITE 600	Suite 600	ROCKVILLE	MD	20852	521317896	501(c)(3)	59593	0	N/A	N/A	HVTN LABORATORY PROGRAM
INDIANA UNIVERSITY
P O BOX 66057		INDIANAPOLIS	IN	462666057	356001673	University	98232	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F	FINANCIAL MANAGEMENT SUPPORT
INSTITUTE FOR SYSTEMS BIOLOGY
1441 NORTH 34TH STREET		SEATTLE WA	WA	981038904	912003593	501(c)(3)	1175279	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF
INSTITUTE FOR SYSTEMS BIOLOGY
1441 NORTH 34TH STREET		SEATTLE WA	WA	981038904	912003593	501(c)(3)	116104	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD
INVITROGEN CORPORATION
12088 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	330373077	Public Company	82608	0	N/A	N/A	VALIDATION OF AN AUTOANTIBODY SIGNATURE FOR BREAST CANCE
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595008	501(c)(3)	169745	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	BANK OF AMERICA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595008	501(c)(3)	136445	0	N/A	N/A	BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS	BANK OF AMERICA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595008	501(c)(3)	26419	0	N/A	N/A	REGULATION OF CENTROMERIC CHROMATIN	BANK OF AMERICA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595008	501(c)(3)	16299	0	N/A	N/A	VALIDATION OF AN AUTOANTIBODY SIGNATURE FOR BREAST CANCE	BANK OF AMERICA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DRIVE		CHICAGO	IL	60693	520595008	501(c)(3)	12823	0	N/A	N/A	GENETIC PROGRESSION OF PANCREATIC MUCINOUS CYSTIC NEOPLA	BANK OF AMERICA
KAISER FOUNDATION HOSPITALS
1800 HARRISON STREET	16TH FLOOR	OAKLAND	CA	946123433	941105628	501(c)(3)	203311	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F	KAISER FOUNDATION RESEARCH INSTITUTE
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	183214	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS; HVTN
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	59657	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: MICRO
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	135103	0	N/A	N/A	CROSS-SPECIES HIV IMMUNOLOGY STATISTICS AND DATA CENTER:
LABKEY CORPORATION
2226 EASTLAKE AVE E	Suite 101	SEATTLE	WA	98102	208266728	501(c)(3)	83834	0	N/A	N/A	CABIG-ISRCE: IN SILICO RESEARCH CENTERS OF EXCELLENCE
LOUISIANA STATE UNIVERSITY HEALTH
433 BOLIVAR ST		NEW ORLEANS	LA	701122223	726087770	PubUnv SpecCtr	35084	0	N/A	N/A	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND	INTERLIBRARY LOAN
MAGEE WOMENS RESEARCH INSTITUTE and
3339 WARD STREET		PITTSBURGH	PA	15213	251462312	501(c)(3)	10164	0	N/A	N/A	HVTN LABORATORY PROGRAM	OFFICE OF RESEARCH ADMINISTRATION
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUE		CAMBRIDGE	MA	02139	042103594	501(c)(3)	421693	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD	CASHIERS OFFICE NE49-3077
MAYO CLINIC ROCHESTER DBA
P O BOX 4008		ROCHESTER	MN	559034008	416011702	501(c)(3)	38053	0	N/A	N/A	GENETIC EPIDEMIOLOGY OF PROSTATE CANCER	REMIT PROCESSING
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	P O BOX 26509	MILWAUKEE	WI	532260509	390806261	University	20157	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION	FINANCE and ADMINISTRATION
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	P O BOX 26509	MILWAUKEE	WI	532260509	390806261	University	7619	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION	FINANCE and ADMINISTRATION
MEDICAL UNIVERSITY OF SOUTH CAROLINA
19 HAGOOD AVE	SUITE 303 MSC 804	CHARLESTON	SC	294258040	576000722	University	13972	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS	CASHIERS OFFICE
MEDICAL UNIVERSITY OF SOUTH CAROLINA
19 HAGOOD AVE	SUITE 303 MSC 804	CHARLESTON	SC	294258040	576000722	University	77380	0	N/A	N/A	HVTN LABORATORY PROGRAM	CASHIERS OFFICE
NEW YORK BLOOD CENTER INC
1200 PROSPECT AVENUE		WESTBURY	NY	11590	131949477	501(c)(3)	1064324	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
P O BOX 415026		Boston	MA	022415026	135562309	University	73722	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	ANTHONY MARSICANO SPONSORED PROGRAMS
NORTHWEST COMMUNITIES EDUCATION CENTER
P O BOX 800		GRANGER	WA	98932	910969818	501(c)(3)	22914	0	N/A	N/A	PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM	KDNA RADIO STATION
OHIO STATE UNIVERSITY RSRCH FOUNDATION
1960 KENNY RD	4TH FLOOR	COLUMBUS	OH	432101063	316401599	501(c)(3)	24081	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE	ACCOUNTING DEPT
OREGON HEALTH and SCIENCES UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	69666	0	N/A	N/A	CANCER INFORMATION SERVICE: BASE PARTNERSHIP PROGRAM NW	SPONSORED PROJECTS ADMINISTRATION
OREGON HEALTH and SCIENCES UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	687349	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF	SPONSORED PROJECTS ADMINISTRATION
OREGON HEALTH and SCIENCES UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	2257977	0	N/A	N/A	IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE	SPONSORED PROJECTS ADMINISTRATION
OREGON HEALTH and SCIENCES UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	56045	0	N/A	N/A	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE	SPONSORED PROJECTS ADMINISTRATION
OREGON HEALTH and SCIENCES UNIVERSITY
2525 SW FIRST AVENUE	SUITE 220	PORTLAND	OR	97201	931176109	University	688507	0	N/A	N/A	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND	SPONSORED PROJECTS ADMINISTRATION
OREGON UNIVERSITY SYSTEM
5219 UNIVERSITY OF OREGON		EUGENE	OR	974035219	936001786	University	34500	0	N/A	N/A	TILLING THE ZEBRAFISH GENOME: A REVERSE GENETICS APPROAC	OFFICE OF RESEARCH SERVICES AND ADMINISTRATION
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	421036007	501(c)(3)	178127	0	N/A	N/A	GENOME-WIDE PROFILING OF HISTONE VARIANTS IN DROSOPHILA
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	421036007	501(c)(3)	18445	0	N/A	N/A	STATISTICAL METHODS FOR PROSPECTIVE EVALUATION OF BIOMAR
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649		BOSTON	MA	022415649	421036007	501(c)(3)	16242	0	N/A	N/A	GENOME-WIDE PROFILINGOF HISTONE VARIANTS IN DROSOPHILA A
PROVIDENCE HEALTH and SERVICES-WASHINGTON
3200 PROVIDENCE DRIVE		ANCHORAGE	AK	99508	920016008	Hospital	67158	0	N/A	N/A	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
PUBLIC HEALTH FOUNDATION ENTERPRISES INC
12801 CROSSROADS PARKWAY SOUTH	SUITE 200	CITY OF INDUSTRY	CA	91746	952557063	501(c)(3)	665005	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE		SEATTLE	WA	981041256	911019655	501(c)(3)	18616	0	N/A	N/A	SURVEILLANCE EPIDEMIOLOGY AND END RESULTS (SEER) PROGR
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE		SEATTLE	WA	981041256	911019655	501(c)(3)	35927	0	N/A	N/A	IN UTERO TRANSPLANTATION IN PRIMATES
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE		SEATTLE	WA	981041256	911019655	501(c)(3)	182624	0	N/A	N/A	THERAPIES FOR HEMATOPOIETIC SYNDROME BONE MARROW STROMA
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	BOX 951432	LOS ANGELES	CA	900959000	956006143	University	108145	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	REMITTANCE CENTER 1125 MURPHY HALL
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	BOX 951432	LOS ANGELES	CA	900959000	956006143	University	39279	0	N/A	N/A	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA	REMITTANCE CENTER 1125 MURPHY HALL
REGENTS OF THE UNIVERSITY OF CA AT LOS
405 HILGARD AVENUE	BOX 951432	LOS ANGELES	CA	900959000	956006143	University	192928	0	N/A	N/A	MARKERS OF B-CELL STIMULATION AS POTENTIAL PREDICTORS OF	REMITTANCE CENTER 1125 MURPHY HALL
REGENTS OF THE UNIVERSITY OF CALIFORNIA
P O BOX 989062		WEST SACRAMENTO	CA	957989062	946036008	University	106480	0	N/A	N/A	A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON ME	CASHIERS OFFICE
REGENTS OF THE UNIVERSITY OF CALIFORNIA
P O BOX 989062		WEST SACRAMENTO	CA	957989062	946036008	University	34712	0	N/A	N/A	STATISTICAL METHODS FOR INTEGRATIVE ANALYSIS OF GENOMICS	CASHIERS OFFICE
REGENTS OF THE UNIVERSITY OF CALIFORNIA
P O BOX 989062		WEST SACRAMENTO	CA	957989062	946036008	University	182268	0	N/A	N/A	BISPECIFIC ANTIBODY ENGINEERING FOR AML RIT	CASHIERS OFFICE
REGENTS OF THE UNIVERSITY OF MICHIGAN
BOX 223131		PITTSBURGH	PA	151212131	386006309	University	12832	0	N/A	N/A	NOVEL MARKERS FOR HCV-RELATED HCC
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957	P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	University	180573	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957	P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	University	79023	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957	P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	University	8554	0	N/A	N/A	INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957	P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	University	41068	0	N/A	N/A	METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
RESEARCH FOUNDATION OF STATE UNIVERSITY
P O BOX 9		ALBANY	NY	122010009	141368361	501(c)(3)	36747	0	N/A	N/A	POPULATION PHARMACOKINETICS / PHARMACODYNAMICS IN NONABL	CASH RECEIPT DEPARTMENT
RUSH UNIVERSITY MEDICAL CENTER
1700 WEST VAN BUREN	ROOM 277	CHICAGO	IL	60612	362174823	University hospital	69464	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	FUND ACCOUNTING
RUSH UNIVERSITY MEDICAL CENTER
1700 WEST VAN BUREN	ROOM 277	CHICAGO	IL	60612	362174823	University hospital	39661	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	FUND ACCOUNTING
SAINT JUDE CHILDRENS RESEARCH HOSPITAL
262 DANNY THOMAS PLACE	MS 271	MEMPHIS	TN	381053678	620646012	501(c)(3)	28492	0	N/A	N/A	LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O
SAINT LOUIS UNIVERSITY
3700 WEST PINE MALL	FUSZ MEMORIAL HALL SUITE 357	SAINT LOUIS	MO	63108	430654872	University	178521	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N	SUITE 500	SEATTLE	WA	981095219	910961784	501(c)(3)	249572	0	N/A	N/A	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	32155	0	N/A	N/A	CELL METABOLISM AND MYC INDUCED GROWTH DEATH AND NEOPL
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	5568	0	N/A	N/A	ALLOIMMUNITY IN AUTOIMMUNE DISEASE
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	9792	0	N/A	N/A	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	77302	0	N/A	N/A	STEM CELL TRANSPLANTATION: BASIC/CLINICAL RESEARCH
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	100437	0	N/A	N/A	FUNCTION OF HUMAN AND MOUSE BETA-GLOBIN LOCUS CONTROL RE
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	10132	0	N/A	N/A	TGF-beta SIGNALING AND COLON CANCER
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	27649	0	N/A	N/A	PREGNANCY MICROCHIMERISM AND AUTOIMMUNE DISEASE
SEATTLE CHILDRENS
P O BOX 34935	DEPT 736	SEATTLE	WA	981241936	910564748	501(c)(3)	55837	0	N/A	N/A	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
SEATTLE INST FOR BIOMED and CLINICAL RES
1660 SOUTH COLUMBIAN WAY	S-151F	SEATTLE	WA	98108	911452008	501(c)(3)	149778	0	N/A	N/A	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
SLOAN KETTERING INSTITUTE FOR
P O BOX 26338		NEW YORK	NY	10087	131924008	501(c)(3)	288324	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION	MSKCC FINANCE GENERAL POST OFFICE
SLOAN KETTERING INSTITUTE FOR
P O BOX 26338		NEW YORK	NY	10087	131924008	501(c)(3)	6858	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER	MSKCC FINANCE GENERAL POST OFFICE
SLOAN KETTERING INSTITUTE FOR
P O BOX 26338		NEW YORK	NY	10087	131924008	501(c)(3)	57830	0	N/A	N/A	HEMATOPOPIETIC STEM CELL TRANSPLANTATION	MSKCC FINANCE GENERAL POST OFFICE
SUNNYSIDE COMMUNITY HOSPITAL INC
P O BOX 719		SUNNYSIDE	WA	98944	911286008	501(c)(3)	56650	0	N/A	N/A	PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM
SWEDISH HEALTH SERVICES
P O BOX 94085		SEATTLE	WA	981249485	910434008	501(c)(3)	52380	0	N/A	N/A	PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING IN M	SWEDISH HEALTH SERVICES GRANTS
SWEDISH HEALTH SERVICES
P O BOX 94085		SEATTLE	WA	981249485	910434008	501(c)(3)	13171	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM	SWEDISH HEALTH SERVICES GRANTS
TRANSLATIONAL GENOMICS RESEARCH INSTITUT
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	371380	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C
TRANSLATIONAL GENOMICS RESEARCH INSTITUT
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	195532	0	N/A	N/A	A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON ME
TRANSLATIONAL GENOMICS RESEARCH INSTITUT
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	669625	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE
TRANSLATIONAL GENOMICS RESEARCH INSTITUT
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	646879	0	N/A	N/A	INFLAMMATION AND THROMBOSIS GENE PATHWAYS AND CARDIOVASC
TRANSLATIONAL GENOMICS RESEARCH INSTITUT
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	903833	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
TRANSLATIONAL GENOMICS RESEARCH INSTITUT
445 N 5TH ST	SUITE 600	PHOENIX	AZ	85004	753065445	501(c)(3)	792215	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENUINE GENETIC VARIANT: THE WO
TRUSTEES OF COLUMBIA UNIVERSITY IN
P O BOX 29789	CU RESEARCH ADMINISTRATIO	NEW YORK	NY	100879789	135598093	501(c)(3)	599772	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	TRUSTEES OF COLUMBIA UNIVERSITY
TRUSTEES OF DARTMOUTH COLLEGE
11 ROPE FERRY ROAD	SUITE 6210	HANOVER	NH	037551404	020222111	501(c)(3)	40405	0	N/A	N/A	ASPIRIN PHARMOCOGENETICS IN THE ASPIRIN/FOLATE POLYP PRE
TRUSTEES OF THE UNIVERSITY OF
P O BOX 785541		PHILADELPHIA	PA	191785541	231352685	501(c)(3)	2066402	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
TRUSTEES OF THE UNIVERSITY OF
3451 WALNUT STREET	P221 FRANKLIN BUILDING	PHILADELPHIA	PA	191046205	231352685	501(c)(3)	247411	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
UNIVERSITY OF ALABAMA BIRMINGHAM
1530 THIRD AVENUE SOUTH	AB 990	BIRMINGHAM	AL	352940109	636005396	University	1046049	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	GRANTS AND CONTRACTS ACCOUNTING
UNIVERSITY OF ARIZONA
P O BOX 3520		TUCSON	AZ	857223520	742652689	University	12928	0	N/A	N/A	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)	SPONSORED PROJECTS SERVICES
UNIVERSITY OF CHICAGO
1225 E 60TH ST		CHICAGO	IL	60637	362177139	501(c)(3)	11546	0	N/A	N/A	TRANSGENERATIONAL MICROCHIMERISM IN PREGNANCY LOSS	OFFICE OF THE COMPTROLLER
UNIVERSITY OF HAWAII
2530 DOLE STREET	SAKAMAKI D200	HONOLULU	HI	96822	996000354	University	21183	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	OFFICE OF RESEARCH SERVICES
UNIVERSITY OF IDAHO
P O BOX 443020		MOSCOW	ID	838443020	826000945	University	26404	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE	OFFICE OF SPONSORED PROGRAMS
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5225	ALBUQUERQUE	NM	871315041	856000642	University	39243	0	N/A	N/A	ENHANCING LONG-TERM 5-A-DAY BEHAVIOR CHANGE IN WORKSITES	HSC CONTRACT AND GRANT ACCOUNTING
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5220	ALBUQUERQUE	NM	871310001	856000642	University	32245	0	N/A	N/A	REDUCING OBESITY AT THE WORKPLACE: A RANDOMIZED TRIAL
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5220	ALBUQUERQUE	NM	871310001	856000642	University	10355	0	N/A	N/A	TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	MSC09 5220	ALBUQUERQUE	NM	871310001	856000642	University	58801	0	N/A	N/A	TREC COORDINATION CENTER
UNIVERSITY OF NO CAROLINA AT CHARLOTTE
9201 UNIVERSITY CITY BOULEVARD		CHARLOTTE	NC	282230001	560791228	University	69740	0	N/A	N/A	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS	FINANCIAL SERVICES/SPONSORED PROGRAMS
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420		ATLANTA	GA	303842420	566001393	University	331330	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT	OFFICE OF SPONSORED RESEARCH
UNIVERSITY OF NORTH CAROLINA
104 AIRPORT DRIVE	SUITE 2200	CHAPEL HILL	NC	275991350	566001393	University	18317	0	N/A	N/A	METHODS FOR EVALUATING VACCINE EFFICACY	OFFICE OF SPONSORED RESEARCH CB #1350
UNIVERSITY OF NORTH CAROLINA
104 AIRPORT DRIVE	SUITE 2200	CHAPEL HILL	NC	275991350	566001393	University	75000	0	N/A	N/A	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS	OFFICE OF SPONSORED RESEARCH CB #1350
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420		ATLANTA	GA	303842420	566001393	University	6167	0	N/A	N/A	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS	OFFICE OF SPONSORED RESEARCH
UNIVERSITY OF PITTSBURGH
3109 CATHEDRAL OF LEARNING		PITTSBURGH	PA	15260	250965591	University	24925	0	N/A	N/A	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE	OFFICE OF RES/COST ACCTG
UNIVERSITY OF PITTSBURGH
3109 CATHEDRAL OF LEARNING		PITTSBURGH	PA	15260	250965591	University	8802	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	OFFICE OF RES/COST ACCTG
UNIVERSITY OF PITTSBURGH
3109 CATHEDRAL OF LEARNING		PITTSBURGH	PA	15260	250965591	University	13142	0	N/A	N/A	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES	OFFICE OF RES/COST ACCTG
UNIVERSITY OF ROCHESTER
910 GENESEE STREET SUITE 200	BROOKS LANDING BUSINESS CENTER	ROCHESTER	NY	146113847	160743209	University	1294217	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	OFFICE OF RESEARCH ACCT and COST STANDARDS
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394	University	40349	0	N/A	N/A	BIOLOGY AND PROGNOSTIC IMPLICATIONS OF FLT3 MUTATIONS IN	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394	University	6867	0	N/A	N/A	GENE-ENVIRONMENT FACTORS IN CHILDHOOD BRAIN TUMORS	FILE NO 52095
UNIVERSITY OF SOUTHERN CALIFORNIA
SPONSORED PROJECTS ACCOUNTING		LOS ANGELES	CA	900742095	951642394	University	73898	0	N/A	N/A	BIOMARKERS FOR RISK IDENTIFICATION AND RISK-BASED THERAP	FILE NO 52095
UNIVERSITY OF TEXAS HEALTH SCIENCES
P O BOX 203382		HOUSTON	TX	772163382	741761309	University	7585	0	N/A	N/A	PROSTAGLANDIN SYNTHESIS GENETICS AND COLORECTAL CANCER	FINANCIAL ADMINSTRATIVE SUPPORT
UNIVERSITY OF TEXAS HEALTH SCIENCES
P O BOX 203382		HOUSTON	TX	772163382	741761309	University	9892	0	N/A	N/A	PREGNANCY MICROCHIMERISM AND AUTOIMMUNE DISEASE	FINANCIAL ADMINSTRATIVE SUPPORT
UNIVERSITY OF TEXAS MD ANDERSON
P O BOX 4390		HOUSTON	TX	772104390	746001118	University hospital	91072	0	N/A	N/A	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD	GRANTS and CONTRACTS ACCOUNTING
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	RM 406	SALT LAKE CITY	UT	841129020	876000525	University	134629	0	N/A	N/A	PROSTAGLANDIN SYNTHESIS GENETICS AND COLORECTAL CANCER	GRANTS and CONTRACTS ACCOUNTING
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE	RM 406	SALT LAKE CITY	UT	841129020	876000525	University	45689	0	N/A	N/A	THE TIME DISTRIBUTION METHOD FOR MEASURING CLINICALLY VA	GRANTS and CONTRACTS ACCOUNTING
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	10763	0	N/A	N/A	VANGUARD CLINICAL CENTER FOR CLINICAL TRIAL and OBSERVATIO
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	31178	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	5460	0	N/A	N/A	ORAL CANCER: MOLECULAR PROFILES and CLINICAL OUTCOMES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	36435	0	N/A	N/A	AVON BREAST CANCER DONATION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	160593	0	N/A	N/A	EARLY INFECTION IN WOMEN EXPOSED MUCOSALLY TO HIV-1
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	63738	0	N/A	N/A	ENHANCING LONG-TERM 5-A-DAY BEHAVIOR CHANGE IN WORKSITES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	94495	0	N/A	N/A	REDUCING OBESITY AT THE WORKPLACE: A RANDOMIZED TRIAL
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	55945	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	40363	0	N/A	N/A	HIV-1 CELLULAR IMMUNITY IN EXPOSED SERONEGATIVES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	94830	0	N/A	N/A	STRATEGIES TO ENHANCE ADOPTIVE TRANSFER T CELL CLONES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	42718	0	N/A	N/A	HEPATITIS B ESL EDUCATION FOR CHINESE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	8017	0	N/A	N/A	MOLECULAR EPIDEMIOLOGY OF TESTICULAR CARCINOMA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	279104	0	N/A	N/A	THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	13399	0	N/A	N/A	INTERDISCIPLINARY STUDIES TO ENHANCE LONG TERM SURVIVAL
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	48521	0	N/A	N/A	MODELING US PROSTATE CANCER TRENDS: PSA TREATMENT and RAC
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	290112	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	31998	0	N/A	N/A	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	365836	0	N/A	N/A	TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	131531	0	N/A	N/A	ASTATINE-211 CONDITIONING FOR NONMYELOABLATIVE HEMOPOIET
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	84814	0	N/A	N/A	THE ROLE OF UNCULTIVATED BACTERIA IN BACTERIAL VAGINOSIS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	25776	0	N/A	N/A	DEVELOPMENT OF A UROLOGICAL CD CELL TYPING SYSTEM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	38627	0	N/A	N/A	EMOTIONAL EXPRESSION AND CANCER CAREGIVERS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	2978390	0	N/A	N/A	HVTN LABORATORY PROGRAM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	139654	0	N/A	N/A	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: MICRO
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	4087438	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	227856	0	N/A	N/A	GENE THERAPY FOR FANCONI ANEMIA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	334404	0	N/A	N/A	CORD BLOOD EXPANSION AND TRANSPLANTATION IN A NON-HUMAN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	58970	0	N/A	N/A	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	35884	0	N/A	N/A	IN UTERO TRANSPLANTATION IN PRIMATES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	98602	0	N/A	N/A	HEMATOPOIETIC CHEMOPROTECTION IN GLIOBLASTOMA PATIENTS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	25388	0	N/A	N/A	SAFEWAY DONATION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	433620	0	N/A	N/A	SEATTLE VACCINE TRIALS UNIT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	127061	0	N/A	N/A	LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	9914	0	N/A	N/A	TGF-beta SIGNALING AND COLON CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	122958	0	N/A	N/A	CYTOTOXIC T CELL RESPONSE TO HSV IN HIV INFECTED PEOPLE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	51632	0	N/A	N/A	QUANTITATIVE METHODS FOR SPECTRAL AND IMAGE DATA IN PROT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	32509	0	N/A	N/A	ADULT LEUKEMIA RESEARCH CENTER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	139391	0	N/A	N/A	ANTI-CD45 RADIOIMMUNOTHERAPY FOR MANTLE CELL LYMPHOMA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	13203	0	N/A	N/A	RESISTANCE AND RESPONSE MECHANISMS TO PROSTATE CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	16442	0	N/A	N/A	POTENTIATING ADOPTIVE T CELL THERAPY BY IMMUNOMODULATION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	30983	0	N/A	N/A	THE FANCONI ANEMIA-BRCA PATHWAY AND CHEMOSENSITIVITY OF
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	1887175	0	N/A	N/A	IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	9361	0	N/A	N/A	HPV: BIOLOGY CLINICAL SIGNIFICANCE AND EPIDEMIOLOGY
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	20357	0	N/A	N/A	NIGHT SHIFT WORK AND HORMONE LEVELS IN MEN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	71628	0	N/A	N/A	IMPROVING GASTROINTESTINAL RECOVERY AFTER RADIATION
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	12758	0	N/A	N/A	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	148465	0	N/A	N/A	CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	125822	0	N/A	N/A	IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	800329	0	N/A	N/A	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	96814	0	N/A	N/A	PRETARGETED RADIOIMMUNOTHERAPY OF CD20+ LYMPHOMAS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	28266	0	N/A	N/A	THE FEASIBILITY OF EARLIER DETECTION OF OVARIAN CANCER U
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	196734	0	N/A	N/A	VALIDATION OF AN AUTOANTIBODY SIGNATURE FOR BREAST CANCE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	52320	0	N/A	N/A	THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	151563	0	N/A	N/A	A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON ME
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	17877	0	N/A	N/A	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	2035770	0	N/A	N/A	CLINICAL EPIDEMIOLOGY AND PATHOGENESIS OF ASYMPTOMATIC H
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	1127454	0	N/A	N/A	FRED HUTCHINSON/UNIVERSITY OF WASHINGTON CANCER CONSORTI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	21293	0	N/A	N/A	OUTCOMES BASED GUIDELINE DEVELOPMENT FOR PROSTATE CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	42578	0	N/A	N/A	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	1134982	0	N/A	N/A	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	110525	0	N/A	N/A	MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	56078	0	N/A	N/A	IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	53574	0	N/A	N/A	CD8+ CELL IMMUNITY TO CYTOMEGALOVIRUS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	134971	0	N/A	N/A	MITIGATION OF RADIATION-INDUCED LUNG INJURY IN THE DOG M
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	139697	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	98050	0	N/A	N/A	CD45 PRETARGETED RADIOIMMUNOTHERAPY FOR AML
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	7941	0	N/A	N/A	DEVELOPMENT OF NOVEL AIDS GENE THERAPY STRATEGIES IN THE
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	8307	0	N/A	N/A	SCHWACHMAN-DIAMOND SYNDROME INTERNATIONAL REGISTRY AND R
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	265239	0	N/A	N/A	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	134139	0	N/A	N/A	INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	42482	0	N/A	N/A	ORAL CANCER: MOLECULAR PROFILES and CLINICAL OUTCOMES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	64482	0	N/A	N/A	CHEMOPROTECTION AGAINST AMINOGLYCOSIDE-INDUCED OTOTOXICI
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	26426	0	N/A	N/A	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	79496	0	N/A	N/A	PRECLINICAL GENE THERAPY STUDIES IN CANINE MUSCULAR DYST
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	6221	0	N/A	N/A	INFLAMMATORY DENDRITIC CELLS IN ADIPOSE TISSUE INFLAMMAT
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	34384	0	N/A	N/A	HPV CAPSID ANTIBODIES
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	75483	0	N/A	N/A	INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	210541	0	N/A	N/A	CONTROLLING HEMATOPOIETIC LINEAGE COMMITMENT FROM ESC TO
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	41792	0	N/A	N/A	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	33469	0	N/A	N/A	THE PATHOGENESIS OF FMD: FACIOSCAPULOHUMERAL MUSCULAR
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	197971	0	N/A	N/A	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	189328	0	N/A	N/A	HPTN NETWORK STATISTICAL AND DATA MANAGEMENT OPERATIONS
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	33072	0	N/A	N/A	LATE EFFECTS OF TREATMENT IN WILMS TUMOR SURVIVORS AND O
UNIVERSITY OF WASHINGTON
12455 COLLECTIONS DRIVE		CHICAGO	IL	606930001	916002008	University	95793	0	N/A	N/A	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C
UNIVERSITY OF WISCONSIN
DRAWER 538		MILWAUKEE	WI	532780538	396006492	University	17862	0	N/A	N/A	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)	OFFICE FOR RESEARCH and SPONSORED PROGRAMS
UNIVERSITY OF WISCONSIN
DRAWER 538		MILWAUKEE	WI	532780538	396006492	University	235276	0	N/A	N/A	CORE ASSASYS MRLI - W1 W3	OFFICE FOR RESEARCH and SPONSORED PROGRAMS
VANDERBILT UNIVERSITY
DEPT AT 40303		ATLANTA	GA	311920303	620477008	501(c)(3)	18250	0	N/A	N/A	MODELING US PROSTATE CANCER TRENDS: PSA TREATMENT and RAC	DEPT OF FINANCE
VANDERBILT UNIVERSITY
DEPT AT 40303		ATLANTA	GA	311920303	620477008	501(c)(3)	522660	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	DEPT OF FINANCE
VANDERBILT UNIVERSITY
DEPT AT 40303		ATLANTA	GA	311920303	620477008	501(c)(3)	46380	0	N/A	N/A	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD	DEPT OF FINANCE
VANDERBILT UNIVERSITY
2301 VANDERBILT PLACE	VU STATION B 351591	NASHVILLE	TN	372351591	620477008	501(c)(3)	70175	0	N/A	N/A	TILLING THE ZEBRAFISH GENOME: A REVERSE GENETICS APPROAC
VANDERBILT UNIVERSITY
DEPT AT 40303		ATLANTA	GA	311920303	620477008	501(c)(3)	14614	0	N/A	N/A	OUTCOMES BASED GUIDELINE DEVELOPMENT FOR PROSTATE CANCER	DEPT OF FINANCE
WAKE FOREST UNIVERSITY
MEDICAL CENTER BOULEVARD	CONTROLLERS OFFICE	WINSTON SALEM	NC	27157	223849199	University	61667	0	N/A	N/A	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT	HEALTH SCIENCES
WASHINGTON STATE UNIVERSITY
P O BOX 641039		PULLMAN	WA	991641039	916001108	University	133039	0	N/A	N/A	ENGINEERING ENZYMES FOR ANTI-TUMOR SUICIDE GENE THERAPY	CASHIERS OFFICE
WASHINGTON STATE UNIVERSITY
P O BOX 641027	FRENCH ADMINSTRATION BLDG	PULLMAN	WA	991641027	916001108	University	288467	0	N/A	N/A	WASHINGTON VACCINE ALLIANCE	ATTN CASHIERS OFFICE-SPS
WASHINGTON UNIVERSITY DBA
700 ROSEDALE AVENUE	CAMPUS BOX 1034	ST LOUIS	MO	631121408	430653611	University	47163	0	N/A	N/A	RADIATION DOSE-DEPENDENT INTERVENTIONS	SPONSORED PROJECTS ACCOUNTING
WEILL MEDICAL COLLEGE OF CORNELL UNIV
100 BROADWAY	8TH FLOOR	NEW YORK	NY	10005	131623978	University	107561	0	N/A	N/A	HVTN LABORATORY PROGRAM	RESEARCH ACCOUNTING DEPARTMENT
WEILL MEDICAL COLLEGE OF CORNELL UNIV
100 BROADWAY	8TH FLOOR	NEW YORK	NY	10005	131623978	University	39478	0	N/A	N/A	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL	RESEARCH ACCOUNTING DEPARTMENT
WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
3601 SPRUCE STREET		PHILADELPHIA	PA	19104	236434390	501(c)(3)	24301	0	N/A	N/A	BARRETT'S ESOPHAGUS: PREDICTORS OF PROGRESSION
YAKIMA VALLEY FARM WORKERS CLINIC
518 W FIRST AVE	PO BOX 190	TOPPENISH	WA	98948	911019392	501(c)(3)	36707	0	N/A	N/A	INTERVENTION TO INCREASE SCREENING FOR CERVICAL CANCER I	CENTRAL ADMINISTRATION
YALE UNIVERSITY
P O BOX 1873		NEW HAVEN	CT	065081873	060646973	501(c)(3)	26091	0	N/A	N/A	TREC COORDINATION CENTER	GRANTS and CONTRACT FINANCIAL ADMIN
YALE UNIVERSITY
P O BOX 1873		NEW HAVEN	CT	065081873	060646973	501(c)(3)	82842	0	N/A	N/A	ADULT LEUKEMIA RESEARCH CENTER	GRANTS and CONTRACT FINANCIAL ADMIN
YALE UNIVERSITY
P O BOX 1873		NEW HAVEN	CT	065081873	060646973	501(c)(3)	15626	0	N/A	N/A	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	GRANTS and CONTRACT FINANCIAL ADMIN
YESHIVA UNIVERSITY
1300 MORRIS PARK AVE	BELFER BLDG RM 1108	BRONX	NY	10461	131624225	501(c)(3)	9972	0	N/A	N/A	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)	ALBERT EINSTEIN COLLEGE OF MEDICINE JACK AND PEARL RESNICK CAMPUS
YESHIVA UNIVERSITY
1300 MORRIS PARK AVE	BELFER BLDG RM 1108	BRONX	NY	10461	131624225	501(c)(3)	7274	0	N/A	N/A	INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS	ALBERT EINSTEIN COLLEGE OF MEDICINE JACK AND PEARL RESNICK CAMPUS

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	58	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	40	TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	SchI_P01_S00_L02	Identifier
Return Reference	Schedule I, Part I, Line 2	ReturnReference
Explanation	Procedures for Monitoring the Use of Grant Funds: Once the notice of award has been received and the Center project ID activated, the subaward can be set up. The structure of the subaward will depend on how the Prime is set up. Generally at the Center, a new purchase order (PO) is requisitioned for each subaward for each year of a project. This allows the Research Coordinator (RC) to closely monitor subaward invoices and encumbrances. For our Subrecipients, it means a separate budget ID and final invoice each year. Carryover between years is not automatic. There are 5 primary steps. 1) Step one is within Office of Sponsored Research (OSR). The Grant Specialist notifies the Contract Specialist that a grant which includes a subaward has been funded, and provides to the Contract Specialist a copy of the award, the signed subaward application (if available) and any special instructions. A signed subaward application is important because it shows that the Subrecipient organization has reviewed and approved the budget and scope of work. 2) The RC sends the Contract Specialist a Subcontract Acquisition Form (SAF). This form provides authorization for the Contract Specialist to issue the subaward, and includes a scope of work, budget, and pertinent subrecipient information. It is necessary to provide the scope of work and budget on the SAF as these items may have changed from what was originally submitted in the subaward application. 3) The Contract Specialist requisitions the subaward PO, which the RC must approve. An e-mail is sent to the RC notifying them that the requisition is pending and requires approval. Because OSR does not have funds commitment authority the RC is required to approve all requisitions. 4) OSR collects information required to correctly set up the subaward. These items include Institutional Review Office (IRO) and Institutional Animal Care and Use Committee (IACUC) approval dates, confirmation of subaward Facilities and Administrative (F&A) rates and A-133 Audit reports, review of Prime special terms and conditions to determine flow-down, confirmation that the Subrecipient is not debarred, and other similar regulatory and administrative requirements. While much of this information is collected by OSR, the RC may, in addition to completing the SAF, be asked to assist in the collection of some of the documentation. 5) OSR writes the subaward agreement, and mails it to the Subrecipient for signature. Some agreements can be signed by OSR before mailing, while others will be sent unsigned. This is determined by the Contract Specialist based on the terms of award and status of administrative and regulatory requirements. A copy of the initial subaward is sent to the RC. Once the subaward has been fully signed, a copy is sent to the RC for their files. No invoices should be approved by the RC until they have received a fully executed agreement.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	X	CompensationCommittee
Independent Consultant	X	IndependentConsultant
Compensation Survey	X	CompensationSurvey
Board Or Committee Approval	X	BoardOrCommitteeApproval
Severance Payment	1	SeverancePayment
Supplemental Nonqual Retire Plan	0	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	0	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	0	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	0	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	0	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	0	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	0	AnyNonFixedPayments
Initial Contract Exception	0	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (26 entries)

Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
Frederick R Appelbaum
484212	0	0	0	0	0	0	0	45952	0	530164	0	0	0
Janell E Baldwin
176776	0	20000	0	0	0	0	0	31714	0	228490	0	0	0
Irwin D Bernstein
263856	0	0	0	0	0	0	0	39551	0	303407	0	0	0
Martin A Cheever
289396	0	0	0	0	0	0	0	39706	0	329102	0	0	0
Jonathan Cooper
222581	0	0	0	0	0	0	0	34271	0	256852	0	0	0
Linda L Gainer
210102	0	20863	0	0	0	0	0	38090	0	269055	0	0	0
Mark T Groudine
387283	0	38430	0	0	0	16500	0	43597	0	485810	0	0	0
Samir M Hanash
329629	0	0	0	0	0	0	0	43216	0	372845	0	0	0
Leland H Hartwell
616822	0	60725	0	0	0	0	0	44464	0	722011	0	0	0
Randall C Main
319400	0	40000	0	0	0	0	0	44464	0	403864	0	0	0
Margaret Juliana McElrath
232806	0	0	0	0	0	14400	0	40576	0	287782	0	0	0
Ulrich W Mueller
217198	0	22000	0	0	0	0	0	48263	0	287461	0	0	0
Howard Albert Nachtrieb
206816	0	25000	0	0	0	0	0	46097	0	277913	0	0	0
Charles N Petty
258428	0	7500	0	0	0	0	0	26633	0	292561	0	0	0
Ross L Prentice
389843	0	0	0	0	0	0	0	44452	0	434295	0	0	0
Robert J Robbins
297038	0	0	0	0	0	6875	0	17296	0	321209	0	0	0
James M Roberts
144840	0	0	0	0	0	0	0	31914	0	176754	0	0	0
Scott N Rusch
177114	0	20000	0	0	0	0	0	36127	0	233241	0	0	0
Steven G Self
266025	0	0	0	0	0	16500	0	47447	0	329972	0	0	0
Douglas J Shaeffer
277478	0	30000	0	0	0	0	0	43476	0	350954	0	0	0
F Marc Stewart
151776	0	0	0	0	0	0	0	28530	0	180306	0	0	0
Rainier F Storb
247098	0	0	0	0	0	0	0	37999	0	285097	0	0	0
Myra H Tanita
383916	0	0	0	0	0	6000	0	39778	0	429694	0	0	0
Barbara Trask
278736	0	0	0	0	0	16500	0	39655	0	334891	0	0	0
Henry F Warden
221650	0	32400	0	0	0	0	0	36626	0	290676	0	0	0
Nancy L Wells
374196	0	36942	0	0	0	0	0	39778	0	450916	0	0	0

Form990 Schedule J Part III Form990ScheduleJPartIII

Field	Value	IRS element (for citing)
Identifier	SchJ_P01_S00_L04	Identifier
Return Reference	Schedule J, Part I, Line 4	ReturnReference
Explanation	Robert J Robbins received a severance payment of $186,179.	Explanation

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (5 entries)

Issuer EINIssuerEIN	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	CUSIP NumberCUSIPNumber
Washington Health Care Facilities Authority
911108929	2007-11-15	5200000	See Schedule O	0	0
Washington Health Care Facilities Authority
911108929	2009-11-24	15381009	Refund bonds issued 11/1/2002	0	0	93978E6G2
Washington Health Care Facilities Authority
911108929	2009-11-24	8842608	Refund bonds issued 11/1/2002	0	0	93978E6G2
Washington Health Care Facilities Authority
911108929	2009-11-24	32093411	Refund bonds issued 11/1/2002	0	0	93978E6G2
Washington Health Care Facilities Authority
911108929	2009-11-24	18735275	Refund bonds issued 11/1/2002	0	0	93978E6G2

Form990 Schedule K Part II Form990ScheduleKPartII (5 entries)

Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Amount DefeasedAmountDefeased	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Working Capital ExpendituresWorkingCapitalExpenditures	Capital ExpendituresCapitalExpenditures	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind
5200000	0	0	35948	32182	5131870	2007	0	1	1
15381009	1466385	14774747	169304	69174	0	2009	1	1	1
8842608	843031	8494066	97333	39769	0	2009	1	1	1
32093411	3059701	30828408	353262	144336	0	2009	1	1	1
18735275	1786172	17996801	206225	84260	0	2009	1	1	1

Form990 Schedule K Part III Form990ScheduleKPartIII (5 entries)

Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Bond Counsel Routinely EngagedBondCounselRoutinelyEngaged	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
0	0	1	0	0	0	1
1	1	1	0.003	0.001	0.004	1
0	0	1	0	0	0	1
0	1	1	0	0.013	0.013	1
0	0	1	0	0	0	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (5 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (3 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer
Washington Health Care Facilities Authority
911108929	93975E6G2	2009-11-24	39972686	Refund bonds issued 11/15/2001	0	0
Washington Health Care Facilities Authority
911108929	93978E6L1	2009-11-24	53597105	Refund bonds issued 11/30/2000	0	0
Washington Health Care Facilities Authority
911108929	93978E6L1	2009-11-24	6237895	Refund bonds issued 11/30/2000	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (3 entries)

Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Amount DefeasedAmountDefeased	Amount UnspentAmountUnspent	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind
39972686	3829025	35516644	0	627017	2009	1	1	1
53597105	0	53037940	130862	428302	2009	1	0	1
6237895	0	6172817	15230	49848	2009	1	0	1

Form990 Schedule K Part III Form990ScheduleKPartIII (3 entries)

Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Bond Counsel Routinely EngagedBondCounselRoutinelyEngaged	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
1	1	1	1	0.007	0.007	0.014	1
0	1	1	1	0.012	0.004	0.016	1
0	0	0	1	0	0	0	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (3 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate	Term Of HedgeTermOfHedge
(no name)
0	0	0	0	0	0
Barclays Bank PLC
0	1	1	0	0	0	18.5
Barclays Bank PLC
0	1	1	0	0	0	18.5

Schedule L IRS990ScheduleL

Form990 Schedule L Part IV Form990ScheduleLPartIV

Name Of Interested Person NameOfInterestedPerson

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	Ikaria Inc	BusinessNameLine1

Field	Value	IRS element (for citing)
Relationship	See Schedule O.	Relationship
Amount Of Transaction	1619438	AmountOfTransaction
Description Of Transaction	See Schedule O.	DescriptionOfTransaction
Sharing Of Revenues	0	SharingOfRevenues

Schedule M IRS990ScheduleM

Works Of Art WorksOfArt

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Number Of Contributions	5	NumberOfContributions
Noncash Contribs Rptd F990	728646	NoncashContribsRptdF990
Method Of Determining Revenues	Appraisal & FMV	MethodOfDeterminingRevenues

Securities Publicly Traded SecuritiesPubliclyTraded

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Number Of Contributions	25	NumberOfContributions
Noncash Contribs Rptd F990	4423619	NoncashContribsRptdF990
Method Of Determining Revenues	Market Value	MethodOfDeterminingRevenues

Other Non Cash Contributions Table OtherNonCashContributionsTable

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Description	Equipment	Description
Number Of Contributions	1	NumberOfContributions
Noncash Contribs Rptd F990	30524	NoncashContribsRptdF990
Method Of Determining Revenues	Selling Price	MethodOfDeterminingRevenues

Field	Value	IRS element (for citing)
Any Property That Must Be Held	1	AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts	0	ReviewProcessUnusualNCGifts
Third Parties Used	1	ThirdPartiesUsed

Form990 Schedule M Part II Form990ScheduleMPartII (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SchM_P01_S00_L00	Schedule M, Part I	Column (b): Organization is reporting the number of contributions.
SchM_P01_S00_L30b	Schedule M, Part I, Line 30b	The Center received an artwork collection of forty Black & White photographs. The donation agreement requires the Center to display the artwork as a collection at its Main Campus in Seattle, Washington for at least twenty years.
SchM_P01_S00_L32b	Schedule M, Part I, Line 32b	The Center employs KMS Financial Services to sell securities received as contributions.

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (10 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
F990_P06_S0B_L00	Form 990, Part VI, Section B	Line 11A - Under the Center's bylaws, the Finance Committee is responsible for reviewing and investigating financial transactions of FHCRC including responsibility for internal and external auditing and for making recommendations to the Board concerning these matters. FHCRC's Vice President of Finance & Chief Financial Officer and his staff works closely with the outside accounting firm FHCRC engages to review the Form 990. The draft of the Form 990 is also reviewed by the Controller, the Executive Vice President & Chief Operating Officer and the Vice President & General Counsel prior to providing it to the Finance Committee. The Finance Committee consults with the Chief Operating Officer, Chief Financial Officer, General Counsel and Controller and such other persons as the Finance Committee may designate to review the draft Form 990. The Finance Committee also meets with the accounting firm hired to assist with preparation of the Form 990. Subsequent to its review, the Finance Committee reports to the Board regarding its oversight of the Form 990. The final draft is provided to the full Board prior to filing the return.
F990_P06_S0B_L11	Form 990, Part VI, Section B, Line 11	The final draft is provided to the full Board prior to filing the return.
F990_P06_S0B_L12c	Form 990, Part VI, Section B, Line 12c	The Executive Committee of the Board is responsible for monitoring conflicts of interest involving trustees or the President & Director of the Center. The President & Director of the Center is responsible for monitoring conflicts of interest involving other officers, scientific staff and other key personnel designated by the President & Director. Under the FHCRC Conflict of Interest Policy and the related Guidelines, an annual conflict of interest disclosure document aimed at determining family and business relationships and transactions that constitute a conflict of interest under the policy, is distributed to and must be completed by all covered persons. Disclosures by trustees and the President & Director are reviewed by the Office of the General Counsel who reports any conflicts to the Executive Committee with recommendations on appropriate terms for a conflict management plan. Conflict management plans for trustees or the President & Director are reviewed and approved by the Executive Committee and signed by the person with the conflict of interest and the Chair of the Board. Disclosures by members of the scientific staff, officers other than the President & Director and other key personnel designated by the President & Director are reviewed by the Office of the President & Director, the Office of the General Counsel, and the Director of the division in which the person has his or her primary appointment or responsibilities. If a conflict is determined to exist under the policy a written conflict management plan is recommended by the Office of the General Counsel and approved and signed by the Office of the Director, the Office of the General Counsel and the Division Director as well as the person who has the conflict. Conflict management plans are designed to manage, reduce or eliminate conflicts to prevent bias, improper influence, or misuse of FHCRC or government resources. The conflict management plans for trustees usually require the affected trustee to recuse himself or herself from voting on any matters involving the affected transaction or relationship although he or she is allowed to provide factual information if requested by the Board or Executive Committee. All transactions requiring Board or committee approval must be approved by a majority of disinterested persons. Conflict management plans involving scientific staff, officer or other key personnel usually impose one of more of the following conditions or restrictions: (i) public disclosure of the interest; (ii) monitoring of research by independent reviewers; (iii) modification of the research plan; (iv) disqualification from participation in all of or a portion of the research by the person with the conflict of interest; (v) divesture of the interest; (vi) severance of the relationship creating the conflict of interest.
F990_P06_S0B_L15	Form 990, Part VI, Section B, Line 15	Line 15a & 15b - Compensation for the President & Director is determined and approved by the Board Compensation Committee. The compensation of other officers and key personnel at FHCRC is determined by the President & Director subject to ratification by the Compensation Committee. The Compensation Committee has developed, consistent with the organization's philosophy and principles, guidelines for determining compensation and benefits. The Compensation Committee also hires a qualified independent compensation specialist ("independent expert") to review, analyze and provide benchmarking data for the total compensation packages of all officers and key employees. Appropriate comparability data is obtained from the independent expert. No person with a conflict of interest may participate in determining or approving any executive compensation. Meetings of the Compensation Committee are documented in minutes which are approved at the next committee meeting. The above process was last undertaken in 2010 for the following positions: Sr VP & Dir, Clin Res Div; VP Shared Resources; Sr VP & Dir, Basic Sci; Sr VP & Co-Dir, VIDI; VP External Affairs & Comm; Sr VP & Deputy Dir, FHCRC; President & Director; VP & Chief Financial Officer; VP Industry Rel & Tech Transfer; VP Human Resources; Sr VP & Dir, PHS; VP Information Tech; Sr VP & Dir, Basic Sci; VP Operations & Facilities; VP General Counsel; Exec VP & COO; Sr VP & Dir, Human Biology; and VP and Dir of Development.
F990_P06_S0C_L19	Form 990, Part VI, Section C, Line 19	While federal tax laws do not mandate that the organization's governing documents, Conflict of Interest Policy and financial statements be made available for public inspection, the organization makes these documents available upon request.
F990_P07_S0B_L01A	Form 990, Part VII, Section B, Line 1(A)	W. LEASE LEWIS COMPANY: 107 SPRING STREET, SUITE 300, SEATTLE, WA, 98104-1052; SPAWA LLC: 1099 ALAKEA ST. SUITE 2220, HONOLULU, HI, 96813; TOWNSEND AND TOWNSEND AND CREW LLP: EIGHTH FLOOR, TWO EMBARCADERO CENTER, SAN FRANCISCO, CA, 94111-3834; KPMG LLP: DEPT 0771, P O BOX 120001, DALLAS, TX, 75312-0771; WOODCOCK WASHBURN LLP: CIRA CENTRE 12TH FLOOR, 2929 ARCH STREET, PHILADELPHIA, PA, 19104-2891.
SchG_P02_S00_L01	Schedule G, Part II, Line 1	Event #1: Hutch Holiday Gala; Event #2: Climb to Fight Breast Cancer.
SchK_P01_S00_L00f	Schedule K, Part I, Column f	Line A, Description of purpose: To reimburse the Center for costs of acquiring real property and improvements and pay issuance costs.
SchL_P04_S00_L00	Schedule L, Part IV	(a) Name of intersted person: Ikaria Inc; (b) Relationship between interested person and the organization: R.Nelson, organization trustee, is > 5% shareholder of Ikaria; (c) Amount of transaction: $1,619,438; (d) Description of transaction: Dividend on shares issued under license and for reimbursement of expenses; (e) Sharing of organization's revenue: No.
SchR_P02_S00_L00	Schedule R, Part II	Primary activity of Seattle Vaccine Research Fund: Anti-retrovital therapy for eligible participants. Address of UPCID: c/o Uganda Cancer Institute, POB 3935, Mulago Hospital, Upper Mulago Hill Road, Kampala, Uganda. Primary activity of UPCID, Ltd: Research and education regarding cancer and infectious diseases. Exempt Code section for UPCID, LTD: Uganda Income Tax Act CAP 340, Section 2(bb). Direct controlling entity for UPCID, LTD: Fred Hutchinson Cancer Research Center.

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EINEIN	Primary ActivitiesPrimaryActivities	Legal Domicile StateLegalDomicileState	Exempt Code SectionExemptCodeSection	Public Charity StatusPublicCharityStatus	Direct Controlling Entity NADirectControllingEntityNA	Address Line1AddressForeign/AddressLine1	CityAddressForeign/City	CountryAddressForeign/Country	Legal Domicile Foreign CountryLegalDomicileForeignCountry	Business Name Line1DirectControllingEntityName/BusinessNameLine1
Seattle Vaccine Research Fund
1100 Fairview Ave North	Seattle	WA	98109	331111221	See Schedule O	WA	501(c)(3)	11a	N/A
UPCID Ltd
					See Schedule O		See Schedule O	N/A		Upper Mulago Hill Road	Kampala	UG	UG	See Schedule O

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	0	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	1	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	0	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	0	LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org	0	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	0	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	0	ExchangeOfAssets
Rental Of Facilities To Other Orgs	0	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	0	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	1	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	0	PerformOfServicesByOtherOrgs
Sharing Of Facilities	0	SharingOfFacilities
Sharing Of Paid Employees	1	SharingOfPaidEmployees
Reimbursement Paid To Other Org	0	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	0	OtherTransferToOtherOrg
Other Transfer From Other Org	0	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable

Name Of Other Organization NameOfOtherOrganization

Field	Value	IRS element (for citing)
Business Name Line1	UPCID Ltd	BusinessNameLine1

Field	Value	IRS element (for citing)
Transaction Type	b	TransactionType
Amount Involved	156000	AmountInvolved